Document:

Settlement and License Agreement dated March 21, 2005

 Exhibit 10.17 
  
 SETTLEMENT AND LICENSE AGREEMENT 
  
 THIS SETTLEMENT AND LICENSE AGREEMENT (the “Agreement”) is made by and among Rambus Inc.
(“Rambus”), on the one hand, and Infineon Technologies AG, Infineon Technologies North America Corp. and Infineon Technologies Holding North America Inc. (collectively, “Infineon”), on the other hand, effective as of March 18,
2005 (“Effective Date”). 
  
 WHEREAS, Rambus and
Infineon have rights under certain U.S. and foreign patents and patent applications including the right to license such patents; 
  
 WHEREAS, Rambus and Infineon are currently parties to a number of disputes and court actions relating to certain memory products and memory
interface technology; 
  
 WHEREAS, Rambus and Infineon wish
to settle such disputes and court actions and all claims between them related thereto; 
  
 WHEREAS, Rambus wishes to grant Infineon a license to U.S. and foreign patents and patent applications relating to memory products, as hereinafter defined, under which Rambus now has, or may hereafter, acquire
any rights, and Infineon wishes to grant Rambus a license to U.S. and foreign patents and patent applications relating to memory interfaces, as hereinafter defined, under which Infineon now has, or may hereafter, acquire any rights 
  
 WHEREAS, Rambus and Infineon have agreed to the conditions, releases,
and other obligations set forth herein as full, final and complete resolution of the claims asserted in such disputes and court actions; and 
  
 WHEREAS, this Agreement is entered into for the purpose of settlement and compromise only, 
  
 NOW, THEREFORE, in consideration of the promises and the mutual
covenants herein contained and for other good and valuable consideration, the adequacy and receipt of which are hereby acknowledged, Rambus and Infineon agree as follows. 
  
 ARTICLE 1 
  
 Definitions 
  
 The following terms used herein with initial capital letters shall have the respective meanings specified in this Article 1. 
  

	1.1	 Affiliate. The term “Affiliate” means any entity controlling, under common control with, or controlled by, a party. The term “control”
means the possession, directly or indirectly, of the power to direct or cause the direction of management or policies (whether through ownership of securities, partnership or other ownership interests, by contract or otherwise), provided that, in
any event, any entity that owns or holds, directly or indirectly, more than fifty percent (50%) of 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 1 

	 	 
the voting securities, partnership or other equity interests of any other entity will be deemed to control such entity. 

  

	1.2	Disputes. The term “Disputes” means the court actions listed hereinafter and any and all disputes related thereto: 

  

	 	(a)	the Richmond patent litigation (Rambus Inc. v. Infineon Technologies AG et al., No. 3:00cv524 (E.D. Va. Filed Aug. 8, 2000) (“The Richmond Patent Litigation”)

  

	 	(b)	the California patent litigation (Rambus Inc. v. Hynix Semiconductor Inc. et al., No. C05-00334 EDL (N.D. Cal. Filed Jan. 25, 2005) (“The California Patent
Litigation”) 

  

	 	(c)	the California anti-trust litigation (Rambus Inc. v. Micron Technology Inc. et al., No. 04-431105 (Supr. Ct. Cal., San Fran. Filed May 5, 2004) (“The California
Anti-trust Litigation”) 

  

	 	(d)	the German Infringement litigations 7-O-317/00; 7-O-301/04 

  

	 	(e)	the German and European patent office actions Gbm9117296 Lö I 183/00; 5W(pat)443/03; XZB28/04; opposition EP 0525068, T0081/03-351, opposition EP 1004956, opposition EP
1022642, opposition EP 1019911, opposition EP 0870241, 

  

	 	(f)	the respective complaints against the other party filed with the European Commission. 

  

	1.3	Leading Suppliers. The term “Leading Suppliers” means, subject to Section 6.6, [***] 

  

	1.4	Licensed Rambus Patents. The term “Licensed Rambus Patents” means all patents, utility models, and patent applications, in all countries of the world having a first
effective filing date, in any country in the world, prior to March 18, 2005 including, without limitation, all reissuances, continuations, continuations-in-part, revisions, extensions and reexaminations thereof, and any patents and patent
applications related thereto, filed or issued in any country of the world, that are owned or controlled by Rambus or any of its Affiliates on March 18, 2005 (and patents that may issue thereon) to the extent Rambus or its Affiliates is entitled to
grant licenses thereunder without the payment of fees to any third party. 

  

	1.5	Infineon Patents. The term “Infineon Patents” means (i) all patents, utility models, and patent applications, in all countries of the world having a first effective
filing date, in any country in the world, prior to March 18, 2005, including, without limitation, all reissuances, continuations, continuations-in-part, revisions, extensions and reexaminations thereof, and any patents and patent applications
related thereto, filed or issued in any country of the world, that are owned or controlled by Infineon or any of its Affiliates on March 18, 2005 (and patents that may issue thereon) to the extent Infineon or its Affiliates is entitled to grant
licenses thereunder without the payment of fees to any third party. Infineon Patents shall not include any patents, utility models, and patent applications, in all countries of the world, pertaining to semiconductor manufacturing or testing
technology. 

  

	1.6	 Infineon Licensed Products. The term “Infineon Licensed Products” means any existing or future Infineon Memory ICs, Infineon Memory Portion,
Infineon Memory Modules, or Infineon Module Component. Notwithstanding the foregoing sentence, the parties agree that Laundry 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 2 

	 	 
Products and Disti Products are excluded from the definition of Infineon Licensed Products. The term Infineon includes Infineon Affiliates for the purpose of
this Section. 

  

	1.7	Laundry Product. The term “Laundry Product” means any product: 

  

	 	(a)	made by or for Infineon or its Affiliates; and 

  

	 	(b)	the design for which product is provided by or on behalf of a third party (“Designing Party”) or owned or controlled by the Designing Party; and 

 

	 	(c)	where such product is supplied by or for Infineon or its Affiliates to the Designing Party or to entities designated by the Designing Party. 

  
 “Disti Product” means any product: 
  

	 	(a)	made by a third party (“Manufacturer”) and acquired by Infineon or its Affiliates; and 

  

	 	(b)	for which Infineon and its Affiliates perform only the packaging, or no, or only insubstantial manufacturing activity, such as (without limitation) only marking of such product or
performing a minor process step on such product; and 

  

	 	(c)	is sold or otherwise transferred to a third party by Infineon or its Affiliates; and 

  

	 	(d)	is not a design owned or controlled by Infineon. 

  
 Notwithstanding the foregoing sentence, a product that meets the above definition of Disti Product shall be deemed not to be a Disti Product if such
products are labeled with a part number and trademark of Infineon or its Affiliates (except such labeling requirement shall not apply for low quality, scrap, or other substandard products) and: 
  

	 	(e)	all or a substantial portion of the manufacturing technology the Manufacturer employs in manufacturing such product is provided by Infineon or its Affiliates; or

  
 Infineon or its Affiliates owns or controls (as
used in the definition as per Section 1.1) at least twenty percent (20%) of the Manufacturer, and Infineon or its Affiliates have participated substantially in the Manufacturer’s acquisition of the manufacturing technology the Manufacturer
employs in manufacturing such product. 
  

	1.8	Memory IC. The term “Memory IC” means any semiconductor memory device, or equivalent, having information storage as its primary function and that is not capable of
performing any substantial data processing that is not related to information storage, retrieval, or error correction, including but not limited to SDR SDRAM, DDR SDRAM, DDR2 SDRAM, DDR3 SDRAM, GDDR2 DRAM, GDDR3 DRAM, RLDRAM, RLDRAM2, RDRAM, XDR
DRAM, Cellular RAM, low power DRAM, SRAM, Flash, MRAM, FRAM, ROM, PROM, EPROM, EEPROM and any subsequent generation of any such products. 

  

	1.9	 Memory Module. The term “Memory Module” means any unitary substrate (for example, silicon, ceramic or PC board) having at least two (2) Memory ICs
or semiconductor devices each having a Memory Portion, physically connected, physically secured or physically stacked onto a unitary substrate device to provide a device having information storage as its primary function, 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 3 

	 	 
where such device itself is not capable of performing any substantial data processing that is not related to information storage, retrieval, error correction
or other functions typically performed by or on a Memory IC. For the avoidance of doubt, devices of the type known as fully buffered DIMMs as of the Effective Date are deemed not to be capable of performing any data processing function that is not
related to memory storage or retrieval and thus are included within the definition of “Memory Modules.” 

  

	1.10	Module Component. The term “Module Component” means any component of a Memory Module other than a Memory IC, provided that such component is marketed by Infineon or
its Affiliates solely to facilitate the functions of a Memory Module. 

  

	1.11	Memory Portion. The term “Memory Portion” means, for any integrated circuit that is not a Memory IC, any portion(s) of such integrated circuit which performs the
functions of a Memory IC, but no other portion of such device. Examples of such excluded portions include without limitation any portion of such device that provides memory controller functionality. An example of a Memory Portion is the memory and
memory related circuitry in an embedded memory device, such as in embedded DRAM, embedded MRAM, and embedded Flash memory. 

  

	1.12	Memory Interface. The term “Memory Interface” means an interface, or portion thereof, between a logic integrated circuit and a memory integrated circuit, whereby
interface shall mean an electrical bus or other similar information path between integrated circuits that is capable of transmitting and/or receiving information between two or more integrated circuits together with the set of protocols defining the
electrical, physical, timing and/or functional characteristics, sequences and/or control procedures of such bus or information path. 

  

	1.13	Qualifying License Agreement. The term “Qualifying License Agreement” means a license agreement, with Rambus as licensor and a Leading Supplier as licensee, for a
license covering [***] and (to the extent that [***] is not one of the aforementioned types of [***] (as defined herein below), where [***] are defined by their respective [***] For the purpose of this Section 1.13, the [***] means the type of [***]
that, during the [***] preceding the date when Rambus and the [***] have both signed the license agreement [***] as published by Gartner-Dataquest (or its successor) [***] (or if not published [***], for the last period of at least [***] for which
such statistic was so published by Gartner-Dataquest (or its successor). A license agreement shall be deemed a Qualifying License Agreement [***] as described herein. 

  

	1.14	Change of Control. The term “Change of Control” of Infineon means a transaction or a series of related transactions in which (i) Infineon, or “control” of
Infineon (where control has the meaning set forth in the definition of the term “Affiliate”), is acquired by one or more third parties (including without limitation a merger in which Infineon is not the surviving entity), or (ii) Infineon
or any of its Affiliates acquires, by merger, acquisition of assets or otherwise, all or substantially all business or assets of a Memory Unit (as defined herein below). For this purpose, a “Memory Unit” means (A) any entity that
manufactures (or has manufactured) and sells Memory ICs, or (B) any division (or other business unit) of an entity, which division (or other business unit) manufactures (or has manufactured) and sells Memory ICs and is responsible for all or
substantially all of such Memory IC manufacturing (or having manufactured) and sales of the entity. 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 4 

 ARTICLE 2 
  

Licenses 
  

	2.1	License Grant to Infineon. Rambus and its Affiliates hereby grant to Infineon and its Affiliates a nonexclusive, worldwide irrevocable license (without the right to grant
sublicenses) under the Licensed Rambus Patents, for the life of such Licensed Rambus Patents, as set forth in Section 2.2. 

  

	2.2	Scope of License. The license granted pursuant to Section 2.1 is a license: 

  

	 	(i)	to make, have made, use, lease, sell, offer to sell, import or otherwise transfer Infineon Licensed Products; and 

  

	 	(ii)	to make, have made, use, lease, sell, offer to sell, import, or otherwise transfer machines, tools, materials, and other instrumentalities, insofar as such machines, tools,
materials, and other instrumentalities are involved in, or incidental to, the development, manufacture, testing, use, or repair of Infineon Licensed Products, provided that the license granted under this Section 2.2 (ii) for lease, sale, offers for
sale or other transfers shall apply only to those machines, tools, materials, and other instrumentalities which Infineon has or its Affiliates have actually used to develop, manufacture, test, use, or repair more than a de minimis quantity of
Infineon Licensed Products. 

  
 For the avoidance
of doubt, to the extent that Infineon or its Affiliates are exercising their have made rights granted in Section 2.2, the license shall include any Infineon Licensed Products made for Infineon by any of Infineon’s existing and future foundry
partners, including but not limited to [***], but only to the extent that such products are sold by Infineon and/or its Affiliates. 
  
 It is the intention of the parties that the principles of patent exhaustion under U.S. law apply to the licenses granted hereunder. Thus, the parties
agree that, at the minimum, in the event a party sells or otherwise disposes of a product licensed hereunder, then to the extent a patent claim licensed hereunder is directly infringed by such product, such claim is exhausted and may not be asserted
against such product regardless of its further use or distribution. 
  
 To the extent that any Rambus patent claim is licensed to Infineon under this Agreement for an Infineon Licensed Product, Rambus and its Affiliates covenant that they will not assert a claim of contributory infringement or inducing
infringement against Infineon or its Affiliates based upon (a) Infineon or its Affiliates performing any of the activities licensed in Section 2.2; or (b) any activities undertaken by any direct or indirect customer or distributor of Infineon or its
Affiliates with respect to such Infineon Licensed Product; or (c) any instructions, information, whitepapers, datasheets or the like that Infineon or its Affiliates may publish or supply with respect to such Infineon Licensed Product. The parties
agree that the foregoing sentence shall not limit Rambus’ or its Affiliates’ rights with respect to any third party. 
  
 To the extent that [***] asserts against any [***] a claim for [***] under this Agreement, Rambus agrees that [***] any such claim [***] that claim
against the [***] and any other entity 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 5 

 
that may have any [***] for the [***] Rambus further agrees that upon any resolution [***] or other entity [***] 
  

	2.3	Most Favored Licensee. If Rambus after [***] enters into, or as soon as Rambus has in effect, an agreement entered into after [***] with any third party (other than an
Affiliate of Infineon) that [***] and has [***] in any one of the prior [***] calendar years, and where such agreement grants to such third party a license for the then current [***] under [***] than those provided [***] for the previous [***]
(where the respective [***] are determined by reports in Gartner Dataquest), then Rambus shall [***] and Infineon shall have the right, in its sole discretion, within [***] by written notice to Rambus, to [***] payments [***] for so long as such
[***] are in effect. For the purpose of this Section 2.3, the [***] means the type of [***] at the effective date or during the term of this license agreement during any given [***] had the [***] (as measured in [***] as published by
Gartner-Dataquest (or its successor) for the [***] preceding the effective date or any [***] during the [***] of the respective license agreement (or if not [***] for the last period of at least [***] for which such statistic was so published by
Gartner-Dataquest (or its successor). 

  

	2.4	Limited License under other Rambus patents. Until Infineon has made the last of the quarterly payments specified under Article 6, but, in any event, at least for the period
of [***], Rambus and its Affiliates hereby grant to Infineon and its Affiliates a nonexclusive, world-wide, irrevocable license (without the right to grant sublicenses), of the same scope as per Section 2.2, under all patents and patent
applications, other than Licensed Rambus Patents, including, without limitation, all reissuances, continuations, continuations-in-part, revisions, extensions and reexaminations thereof, filed or issued in any country of the world, that are owned or
controlled by Rambus or any of its Affiliates now or hereafter (and patents that may issue thereon) to the extent Rambus or its Affiliates is entitled to grant licenses thereunder without the payment of fees to any third party. At the expiration of
the period set forth in this Section 2.4, and subject to Article 3, the licenses granted under this Section 2.4 shall terminate. 

  

	2.5	Infineon License to Rambus. Infineon hereby grants to Rambus and its Affiliates a non-exclusive, non-transferable, worldwide, irrevocable, fully paid license (without the
right to grant sublicenses) under the Infineon Patents, for the life of such Infineon Patents, to make, have made, use, lease, sell, offer to sell, import, or otherwise transfer Memory Interfaces and designs for Memory Interfaces in any form.

  

	2.6	No Implied Licenses. The parties agree that except as expressly granted in this Agreement, there are no patent or other intellectual property licenses or rights granted or
arising hereunder to either party or to any third party, expressly, by implication, estoppel, or under any other legal theory. 

  
 ARTICLE 3 
  
 License Request 
  

	3.1	Upon request of Infineon, Infineon and its Affiliates shall be entitled to obtain and Rambus shall grant an additional license of the same scope as per Section 2.4, at the then
applicable most favored licensee terms and conditions. During the period of [***] following the later of (i) Infineon’s last quarterly payment under this Agreement or (ii) [***], the terms and conditions of this additional license may not
exceed a quarterly payment of [***]. 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 6 

	3.2	Any payments made by [***] granted in accordance with Section 3.1 shall be [***] be obligated [***] obligations according to Section [***] are [***] under Section [***] of Section
[***]. Additionally, [***] Infineon makes payments in accordance with Section [***] receives notice from Rambus of [***] that [***] Section [***] Infineon shall [***] during the full period that it makes payments under Section [***] Sections [***]
beginning on the date of notice of [***]. For example, [***] Section [***] and made [***] before receiving [***] on [***] will be treated as [***] beginning [***] 

  

	3.3	Further, upon request of Infineon, Infineon and its Affiliates shall be entitled to obtain and Rambus shall grant to Infineon and its Affiliates a license under any patents, utility
models, and patent applications, including, without limitation, all reissuances, continuations, continuations-in-part, revisions, extensions and reexaminations thereof, filed or issued in any country of the world, that are owned or controlled by
Rambus or any of its Affiliates now or hereafter (and patents that may issue thereon) to the extent Rambus or its Affiliates is entitled to grant licenses thereunder without the payment of fees to any third party, for [***] at the then applicable
most favored licensee terms and conditions. 

  
 ARTICLE 4 
  
 Releases 
  

	4.1	Releases by Rambus. 

  

	 	(a)	Patent Release. Rambus hereby irrevocably releases, acquits and forever discharges any and all patent infringement claims it has or may have had against any entity’s
making, having made, using, leasing, selling, offering to sell, importing or otherwise transferring any Infineon Licensed Product where such activity took place prior to the effective date, solely to the extent that such activity, had it occurred
after the Effective Date would be licensed under Article 2 of this Agreement. For the avoidance of doubt, and because Inotera is a defendant in the California Patent Litigation, to the extent that Infineon or its Affiliates were having Infineon
Licensed Products made by Inotera prior to the Effective Date, and to the further extent that such activity would be within the license granted to Infineon and its Affiliates in Article 2 of this Agreement had such activities occurred after the
Effective Date, the release granted in the preceding sentence shall extend to the benefit of Inotera for such activities. 

  

	 	(b)	General Release. Rambus hereby irrevocably releases, acquits, and forever discharges Infineon, its Affiliates, its and their respective former or current directors, officers,
and employees from any claims, counterclaims, demands, damages, debts, liabilities, accounts, actions and causes of action of any kind and nature (including, without limitation, patent infringement, antitrust, unfair competition, conspiracy or
competition based claims), whether known or unknown, suspected or unsuspected, throughout the world, that (i) were asserted by Rambus in the Disputes, or (ii) could have been asserted by Rambus. 

  

	 	(c)	Releases between Rambus and Siemens. Rambus and Siemens each grant the other the release as set forth in Exhibit 4.1(c) hereto. 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 7 

	4.2	Releases by Infineon. 

  

	 	(a)	Patent Release. Infineon hereby irrevocably releases, acquits and forever discharges any and all patent infringement claims it has or may have had against any entity’s
making, having made, using, leasing, selling, offering to sell, importing or otherwise transferring any products or designs where such activity took place prior to the Effective Date, solely to the extent that such activity, had it occurred after
the Effective Date would be licensed under Article 2 of this Agreement. 

  

	 	(b)	General Release. Infineon irrevocably releases, acquits and forever discharges Rambus, its Affiliates, and its and their respective former or current directors, officers, and
employees from any claims, counterclaims, demands, damages, debts, liabilities, accounts, actions and causes of action of any kind and nature (including, without limitation, patent infringement, antitrust, unfair competition, conspiracy or
competition based claims), whether known or unknown, suspected or unsuspected, throughout the world, that (i) were asserted by Infineon in the Disputes, or (ii) could have been asserted by Infineon. 

  

	4.3	Releases Shall Remain Effective. Each of Rambus and Infineon acknowledges that, after entering into this Agreement, they may discover facts different from, or in addition to,
those they now believe to be true with respect to the conduct of the other party. Each of Rambus and Infineon intends that the releases and discharges set forth in this Article 4 shall be, and shall remain, in effect in all respects as written,
notwithstanding the discovery of any different or additional facts. 

  

	4.4	Waiver of California Civil Code § 1542. In connection with the releases and discharges described in this Article 4, each of Rambus and Infineon acknowledges that it is
aware of the provisions of section 1542 of the Civil Code of the State of California, and hereby expressly waives and relinquishes all rights and benefits that it has or may have had under that section (or any equivalent law or rule of any other
jurisdiction), which reads as follows: 

  

	
	A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY
AFFECTED HIS SETTLEMENT WITH THE DEBTOR.

  

	4.5	Stipulations and Orders for Dismissal. 

  

	 	(a)	Concurrent with the execution of this Agreement, Infineon, its respective Affiliates, and Rambus, shall execute stipulations and orders for the dismissal with prejudice of all
claims and counterclaims against one another and between Rambus and Siemens in The Richmond Patent Litigation, the California Patent Litigation and the California Anti-trust Litigation in the form attached hereto as Exhibit 4.5.

  

	 	(b)	 Rambus shall within ten (10) business days of the Effective Date, file a motion to withdraw with prejudice any of its infringement claims against Infineon and its
Affiliates pending at the Federal Court of Mannheim (Landgericht Mannheim), Germany. Likewise, within ten (10) business days of the Effective Date, Infineon shall file a motion 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 8 

	 	 
to withdraw with prejudice all its office actions pending at the German and European Patent offices and or patent courts against any of the Licensed Rambus
Patents. To the extent a withdrawal of an action is not possible, Infineon shall within ten (10) business days of the Effective Date inform the respective patent office or patent court that Infineon does no longer actively pursue such action.

  

	4.6	Costs and Attorneys’ Fees. 

  
 For the infringement claims pending at the Federal Court of Mannheim (Landgericht Mannheim), Germany, and the case of the utility model (Gbm 9117296U1)
Rambus shall bear the responsibility for and pay the court fees, and in case of the utility model, the court and patent office fees. 
  
 For all cases, the parties agree that each will pay its respective attorneys’ fees. 
  
 Both parties will, within ten (10) business days following the Effective Date, inform the European Commission that they have
settled their disputes and that they no longer wish to actively pursue those aspects of the complaints the parties have filed against each other or against Siemens AG and its Affiliates. 
  
 Both parties will, within ten (10) business days following the Effective Date, inform the United States Federal Trade
Commission that they have settled their disputes. 
  

	4.7	No Admission. Nothing contained in this Agreement, or done or omitted in connection with this Agreement, is intended as, or shall be construed as, an admission by any party
of any fault, liability or wrongdoing. 

  

	4.8	No Contest. Infineon and its Affiliates agree that they shall not contest in any proceeding the validity, scope, or enforceability of any of the Licensed Rambus Patents or
any claim thereof. except to the extent that Rambus assert any claim of infringement of any such patent against Infineon or its Affiliates. Rambus and its Affiliates agree that they shall not contest in any proceeding the validity, scope, or
enforceability of any of the Infineon Patents or any claim thereof except to the extent that Infineon assert any claim of infringement of any such patent against Rambus or its Affiliates. 

  
 ARTICLE 5 
  
 Term 
  

	5.1	 Term. The term of this Agreement shall be from the Effective Date until the expiration of the last to expire of the Licensed Rambus Patents. Neither party
may terminate this Agreement for any reason prior to its expiration. This Agreement is based upon an assumption shared by both parties that in the Richmond Patent Litigation there have been no substantive findings or judgments (related to any claims
or defenses of the parties) entered since the completion of trial and prior to filing the stipulation of dismissal referenced herein, other than any findings or judgments either reflected in the docket printout attached hereto as Exhibit 5.1, or
known by the parties (e.g. due to their inquiry with the Court and Clerk’s Office prior to filing the stipulation of dismissal). If this assumption proves to be incorrect, either or both of the parties understand that they may move pursuant to
Rule 60 of the Federal Rules of Civil Procedure for relief from any 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 9 

	 	 
judgment or stipulation dismissing the case with prejudice, and to the extent that the motion is granted and has the effect of returning the case to its
state just prior to the filing of the stipulation of dismissal, then this Agreement shall be null and void. 

  

	5.2	Survival. The provisions of Articles 1, 3, 4, 5, 7, 9, 10 and 12 shall survive expiration of this Agreement. 

  
 ARTICLE 6 
  
 Payment 
  

	6.1	Notification of Qualifying License Agreements. Within thirty (30) days of each date on which a Leading Supplier becomes or ceases to be subject to a Qualifying License
Agreement, Rambus shall notify Infineon of the existence of such Qualifying License Agreement, provided that Rambus’ failure to provide such notice in a timely fashion shall not constitute a breach of this Agreement. 

 

	6.2	Payments to First Cap. Subject to Section 6.5, Infineon shall pay Rambus for each calendar quarter starting October 1, 2005 an amount of five million and eight hundred fifty
thousand U.S. dollars (US $5,850,000), up to a cumulative amount not exceeding fifty million U.S. dollars (US $50,000,000) (the “First Cap”). 

  

	6.3	Payments to Second Cap. Subject to Section 6.5, and upon Rambus’ notice to Infineon of the existence of a [***] with each of [***], and further for so long as these
[***] remain in effect during the period [***] Infineon shall continue to pay, or – as the case may be - shall resume payment for each calendar quarter following such notice of [***] an amount of five million and eight hundred fifty thousand
U.S. dollars (US $5,850,000) up to a cumulative amount not exceeding one hundred million U.S. dollars (US $100,000,000), including payments to the First Cap (the “Second Cap”). Notwithstanding anything to the contrary in the foregoing
sentence, in the event that Rambus fails to provide timely notice of [***] pursuant to Section 6.1, but later provides such notice, Infineon’s payment obligations under this Section 6.3 shall commence upon such notice. In the event Infineon
resumes making payments towards the Second Cap at any point in time, Rambus hereby releases Infineon and its Affiliates from any patent infringement claims under patents other than Licensed Rambus Patents, it may have or may have had for making,
having made, using, selling, offering to sell, importing or otherwise transferring any Licensed Products where such activity took place prior to date of resuming such payments. 

  

	6.4	 Payments to Final Cap. Subject to Section 6.5, and upon Rambus’ notice to Infineon of the existence of [***] with each of the [***] and further for so
long as these [***] remain in effect during the period [***] Infineon shall continue to pay, or – as the case may be - shall resume payment for each calendar quarter following such notice of [***] an amount of five million and eight hundred
fifty thousand U.S. dollars (US $5,850,000) up to a cumulative amount not exceeding one hundred fifty million U.S. dollars (US $150,000,000), including payments to the Second Cap (the “Final Cap”). Notwithstanding anything to the contrary
in the foregoing sentence, in the event that Rambus fails to provide timely notice of the existence of the [***] pursuant to Section 6.1, but later provides such notice, Infineon’s payment obligations under this Section 6.4 shall commence upon
such notice. In the event Infineon resumes making payments towards the Final Cap at any point in time, Rambus hereby releases Infineon and its Affiliates 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 10 

	 	 
from any patent infringement claims under patents other than Licensed Rambus Patents, it may have or may have had for making, having made, using, selling,
offering to sell, importing or otherwise transferring any Licensed Products where such activity took place prior to date of resuming such payments. 

  

	6.5	Cessation of Payment Obligations. Except as set forth in Sections 6.3 and 6.4, and subject to Sections 9.1 and 9.4, Infineon shall have no further obligation to make, and may
elect at any time to discontinue making, payments under this Agreement once payments by Infineon to Rambus under this Agreement have reached a cumulative aggregate amount equal to the respective applicable cap as per Sections 6.2, 6.3 or 6.4 and
Infineon shall in no event have any obligation to pay a cumulative aggregate amount exceeding one hundred fifty million U.S. dollars (US $150,000,000).  

  

	6.6	Changes in Identity or Status of Leading Suppliers. 

  

	 	(a)	Except as set forth in Sections 6.6 (b), (c) and (d), in the event that a Leading Supplier ceases to do business (“Former Leading Supplier”), the entity that has [***]
(for the last reported calendar year prior to such cessation of business) [***] according to Gartner-Dataquest publications “[***] or any successor report thereto, that was not previously a Leading Supplier shall be deemed a Leading Supplier in
place of the Former Leading Supplier. 

  

	 	(b)	In the event that a Leading Supplier (or all or substantially all of its [***] business and/or assets) is acquired by an entity that is not a Leading Supplier (including without
limitation Infineon or its Affiliates), such acquiring entity shall be deemed substituted as such Leading Supplier. 

  

	 	(c)	In the event that one or more Leading Supplier(s) (or all or substantially all of its [***] business and/or assets) is acquired by an entity that is a Leading Supplier, such
acquiring entity shall be deemed to constitute either two (2) Leading Suppliers (in the event of the acquisition of a single other Leading Supplier) or three (3) Leading Suppliers (in the event of the acquisition of both other Leading Suppliers).

  

	 	(d)	In the event that a Leading Supplier acquires rights under this Agreement pursuant to Sections 9.1 or 9.4, such Leading Supplier or the resulting entity, as applicable, shall be
deemed to be a Leading Supplier and this Agreement shall be deemed a Qualifying License Agreement. 

  

	6.7	Wire Transfer. Payments owed under this Agreement shall be made by wire transfer to 

  
 Rambus Inc., Account [***] 
 SWIFT Account: [***] 
 [***] 
 [***] 
 [***] 
 ABA # [***] 
  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 11 

 within forty-five (45) days after the end of each calendar quarter. The first such payment shall be due
on November 15, 2005. Rambus shall promptly acknowledge receipt of such payment in writing to Infineon. 
  
 Any payments to Rambus hereunder shall be in United States dollars. 
  
 Infineon shall be entitled to deduct and pay to the German government any withholding taxes imposed by the German
government, in accordance with U.S.-German tax treaties, on any payments payable to Rambus pursuant to this Agreement. Infineon shall promptly provide Rambus with copies of official tax receipts showing that such payments have been made. 

 

	6.8	Late Payments. Any payment not received in full by Rambus when due hereunder shall bear interest at the rate of twelve percent (12%) annually (or, if less, the maximum
allowed by applicable law) computed for the period beginning on the date such payment is due and ending upon Rambus’ receipt of such payment with applicable interest. 

  
 ARTICLE 7 
  
 Warranties 
  

	7.1	Authority. Rambus represents and warrants that it has the full right and power to grant the licenses, rights, releases and discharges, and to make the covenants, set forth in
Articles 2, 3 and 4, that there are no outstanding agreements, assignments or encumbrances inconsistent with the provisions of such licenses, rights, releases and covenants and/or with any other provision of this Agreement, and that neither Rambus
nor any of its Affiliates owns, or has the right to grant licenses under, any patents or pending patent applications in the United States or any country which are not Licensed Rambus Patents, except those patents for which Rambus or its Affiliates
may grant licenses only if it pays a fee to a third party. Rambus shall indemnify and hold harmless Infineon and its Affiliates from any claims of a third party based on such third party’s claim of any rights, title or ownership in or under any
of the Licensed Rambus Patents. Infineon represents and warrants that it has the full right and power to grant the licenses, rights, releases and discharges, and to make the covenants, set forth in Articles 2 and 4, that there are no outstanding
agreements, assignments or encumbrances inconsistent with the provisions of such licenses, rights, releases and covenants and/or with any other provision of this Agreement, and that neither Infineon nor any of its Affiliates owns, or has the right
to grant licenses under, any patents or pending patent applications in the United States or any country which are not Infineon Patents, except those patents for which Infineon or its Affiliates may grant licenses only if it pays a fee to a third
party. Infineon shall indemnify and hold harmless Rambus and its Affiliates from any claims of a third party based on such third party’s claim of any rights, title or ownership in or under any of the Infineon Patents licensed hereunder.

  

	7.2	No Assignment of Claims. Each party represents and warrants that it has not assigned any claim or cause of action, or any right(s) underlying any claim or cause of action, it
had, has, or may have against the other or its Affiliates as of, or prior to, the Effective Date of this Agreement. 

  

	7.3	No Parent Entities. Rambus Inc. and Infineon Technologies AG each respectively represent and warrant that as of the Effective Date, it is not controlled by any other entity,
as control is defined in the defined term Affiliate. 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 12 

 ARTICLE 8 
  

Notices and other Communications 
  
 Any notice or other communication required or permitted to be made or given to either party pursuant to this Agreement shall be sufficiently made or given
within fifteen (15) days of the date of mailing if sent to such party by registered First Class mail, postage prepaid, addressed to such party at the address set forth below, or to such other address as a party shall designate by written notice
given to the other party: 
  
 In the case of Infineon: 

 
 Infineon Technologies AG 
 General Counsel 
 St.-Martin-Straße 53

 81669 München 
 Germany

 Fax: +49 89 234 26983 
  
 In the case of Rambus: 
  
 Rambus Inc. 
 John Danforth 
 Senior Vice President and General Counsel 
 4440 El Camino Real 
 Los Altos, CA 94022 
 Fax: +1 650 947 5001 
  
 (with a
copy, which shall not constitute notice, to the following:) 
  
 Robert Eulau 
 Chief Financial Officer 
 Rambus Inc. 
 4440 El Camino Real 
 Los Altos, CA 94022 
  
 ARTICLE 9 
  
 Assignments 
  
 Assignment by Infineon.
Infineon may [***] except that subject to Section 9.6, Infineon shall have the right, [***] (respectively to the extent specified in the last sentence of this Section 9.1)) under this Agreement [***] of this Agreement which shall [***] whether by
way of merger, acquisition, corporate reorganization, the sale of all, or substantially all, assets of its business, or otherwise expressly or by operation of law, provided that the [***] including without limitation all of [***] pursuant to
this Agreement, and provided further that, effective as of the effective date of the Assignment: 
  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 13 

	 	(a)	if there is no Assignee License Agreement, then [***] (as hereinafter defined) [***] in the last [***] immediately preceding the Assignment and [***] in the last [***]
immediately preceding the Assignment. 

  
 For
example if Infineon’s [***] prior to the Assignment was [***] and Infineon [***] then the [***] prior to the Assignment was [***]. If further the [***] as per (i) [***] as per (ii) [***], then the following [***] shall apply: the [***]
following the Assignment shall be [***] the [***] shall be unchanged at [***] and the applicable [***] the respective [***] pursuant to Sections [***] shall be [***] 
  

	 	(b)	If there is an Assignee License Agreement, then Rambus and the Successor Entity shall negotiate, diligently and in good faith, an appropriate [***], if applicable, under this
Agreement to account for any additional [***] under this Agreement resulting from the Assignment. If within [***] and the [***] do not reach agreement on the [***] 

  
 [***], considering that it is the intent of the parties that: 
  

	 	(1)	Distribution of a [***] should not obligate the [***] to [***] under both [***] above and under the terms of the Assignee License Agreement. 

  

	 	(2)	If, after the effective date of the Assignment, no [***] is the [***] then, prospectively, [***] shall apply. 

  

	 	(3)	Rambus should be able to [***], with respect [***] that would be payable if there were no Assignee License Agreement. The extent of such benefits shall be determined according to
the [***] 

  

	 	(4)	Rambus should not receive [***] as a result of the Assignment than if there were no Assignee License Agreement. 

  

	 	(5)	Any late payments resulting from this negotiation and/or arbitration shall bear interest at the rate of twelve percent (12%) (or, if less, the maximum allowed by applicable law) per
year, from the date that such payment would otherwise have been due 

  
 (For example, [***] provided for payment to Rambus of [***] for the right to make and sell up to [***] then Rambus would retain this [***] but there would be [***] of the [***] By way of further example, if [***]

  
 The parties shall meet within [***] after the Effective Date
to discuss additional such principles and further details of such principles. 
  
 For the purpose of this Section 9.1: 
  
 “[***] Sales” shall mean the worldwide value in U.S. dollars of sales, transfers and other distributions of [***]. 
  
 “Infineon” means Infineon and its Affiliates. 
  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 14 

 [***] means the type of [***] during the [***] preceding the effective date of the Assignment, had the
[***] as published by Gartner-Dataquest (or its successor) [***] for which such statistic was so published by Gartner-Dataquest (or its successor). 
  
 “Assignee” means the entity to which this Agreement is assigned (or, if a series of related assignments pursuant to a series of related
transactions, the entity that is the assignee of this Agreement pursuant to the last such assignment and is therefore the ultimate holder of this Agreement), and its Affiliates. 
  
 “Assignee License Agreement” means an agreement, if any, pursuant to which, as of the effective moment of the
Assignment, the Assignee is licensed by Rambus to make, use, and sell one or more types of [***] (“Assignee Licensed DRAMs”), provided that one of the Assignee Licensed DRAMs is the [***]. 
  
 It is understood and agreed that upon any Assignment of this Agreement by
Infineon, all references to “Infineon” in the body of this Agreement (except Section 1.2) shall be deemed to be references to the Assignee, including without limitation all references to “Infineon” in Sections 1.6 and 1.7.

  
 It is understood that, subject to [***], the [***]
(respectively to the extent specified in the last sentence of this Section 9.1) shall [***] as of the corresponding scope as per [***], and further [***] (with respect to Leading Suppliers). [***] 
  

	9.2	Assignment by Rambus. Rambus may not transfer or assign any rights or licenses under this Agreement, except that Rambus shall have the right, without the approval of
Infineon, to assign this Agreement to any successor to all or substantially all of Rambus’ business or assets, provided that the licenses granted to Rambus and its Affiliates hereunder shall terminate in the event of such assignment. For the
avoidance of doubt, also the assignee of this Agreement shall not be licensed under the assigned Agreement. 

  

	9.3	Assignment of Patents. Any assignment or transfer by a party hereto of all or part of its ownership interest in any patent or patent application owned or controlled by the
party shall be subject to this Agreement and to all amendments, modifications, replacements, and extensions of this Agreement. Any such assignment or transfer shall not make any commitments to others inconsistent with, or in derogation of, any
rights granted to the other party in this Agreement, and such assignee or transferee shall take subject to the pre-existing rights. 

  

	9.4	Change of Control of Infineon. 

  
 For the purpose of this Section 9.4: 
  
 “[***] Sales” shall mean the worldwide value in U.S. dollars of sales, transfers and other distributions of [***]. 
  
 “Infineon” means Infineon and its Affiliates. 
  
 [***] means the type of [***] during the last [***] preceding the effective
date of the [***], had the [***] as published by Gartner-Dataquest (or its successor) [***] for the last period of at least [***] for which such statistic was so published by Gartner-Dataquest (or its successor). 
  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 15 

 “Successor Entity” means the entity resulting from a Change of Control. 
  
 “Prior Entities” means all of the entities (including without
limitation companies and business units of companies) that, after the Change of Control, comprise the Successor Entity, and their Affiliates. as such entities and their Affiliates existed immediately preceding the Change of Control, but excluding
Infineon and it Affiliates as they existed immediately preceding the Change of Control. 
  
 “Prior Entities License Agreement” means an agreement, if any, pursuant to which, as of the effective moment of the Change of Control, any of the Prior Entities is licensed by Rambus to make, use, and sell
one or more types of [***] (“Prior Entities Licensed DRAMs”) provided that one of the Prior Entities Licensed DRAMs is the [***]. 
  

	 	(a)	if there is no [***], then upon a [***] the payment obligations under this Agreement shall be [***] immediately preceding the [***] immediately preceding the [***]

  
 For example [***] prior to the [***] and [***]
had already paid [***] then the payment obligations prior to the [***] as per (i) [***] as per (ii) [***] then the following adjustment shall apply: the [***] following the [***] shall be [***] 
  

	 	(b)	If there is a [***], then Rambus and the Successor Entity shall negotiate, diligently and in good faith, an appropriate [***] under this Agreement resulting from the Change of
Control. If within [***] after the [***] 

  
 The
parties shall negotiate, and the arbitrator shall render his decision, considering that it is the intent of the parties that: 
  

	 	(1)	Distribution of a [***] should not obligate the [***] to [***] under both [***] above and under the terms of the [***]. 

  

	 	(2)	If, after the effective date of the Change of Control, no [***] is the [***] then, prospectively, [***] shall apply. 

  

	 	(3)	Rambus should be able to [***], with respect [***], to the extent such [***] that would be payable if there were no [***]. The extent of such benefits shall be determined according
to the [***] 

  

	 	(4)	Rambus should not receive less [***] than if there were no [***] 

  

	 	(5)	Any late payments resulting from this negotiation and/or arbitration shall bear interest at the rate of twelve percent (12%) (or, if less, the maximum allowed by applicable law) per
year, from the date that such payment would otherwise have been due. 

  
 (For example, [***] provided for payment to Rambus of [***] for the right to make and sell up to [***] then Rambus would retain this [***] but there would be [***] of the [***] By way of further example, if [***]

  
 The parties shall meet within [***] after the Effective Date
to discuss additional such principles. 
  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 16 

 It is understood and agreed that upon any [***] in which [***] is merged into a successor, all references
to [***] in the body of this Agreement [***] shall be deemed to be references to the [***], including without limitation the references to [***] in [***] 
  
 It is understood that, subject to [***], the [***] (respectively to the extent specified in the last sentence of this paragraph) shall fully extend to the
entity resulting from the [***] and any entity resulting from a [***], subject to such resulting entity’s [***], and further [***] 
  
 In addition, upon any Change of Control of Infineon in which Infineon becomes controlled (as “control” is defined in the definition of
“Affiliate”) by an Affiliate, then Infineon shall be entitled, on written notice to Rambus, to Assign this Agreement, in accordance with Section 9.1, to any of its Affiliates that controls Infineon. 
  

	9.5	Impermissible Assignments Null and Void. Any purported transfer or assignment of this Agreement not expressly permitted under this Article 9 shall be null and void and of no
effect. 

  

	9.6	Limited Extension of Releases. Notwithstanding anything to the contrary contained in this Agreement, the [***] set forth in [***] and granted, extended and/or transferred to
a [***], or to [***], may only be so granted, extended and/or transferred to such entity if (a) such entity is not a [***] as of the Effective Date); or (b) such entity is a [***] as of the Effective Date (or a successor to all or substantially all
of the assets and liabilities of a [***] as of the Effective Date) [***], been granted, extended and/or transferred to a [***] 

  

	9.7	Arbitration for purposes of Section 9.1 and 9.4: 

  
 The arbitration shall be under the then current International rules of the American Arbitration Association, subject to the additional limitations set
forth herein, and shall take place in New York, New York. The arbitration shall be conducted by a single arbitrator appointed in accordance with such rules. Each party to the arbitration shall prepare a written proposal setting forth its position
with respect to the substance of the dispute. Without delaying the arbitration procedures, for a period not to exceed three (3) days commencing no later than fifteen (15) days after the arbitrator has been selected, the parties shall exchange and
discuss their respective written proposals in good faith in an effort to resolve the matter. The arbitrator shall select one of the requested positions as his decision, and shall not have authority to render any substantive decision other than to so
select the position of either Rambus or the Successor Entity. If one party does not submit to the arbitrator a written proposal setting forth its position within the time period established by the arbitrator therefor, the arbitrator shall select the
other party’s position. The costs of such arbitration shall be shared equally by the parties, and each party shall bear its own expenses in connection with the arbitration. The parties shall use good faith efforts to complete arbitration under
this section within ninety (90) days following a request by a party for such arbitration. Likewise, the arbitrator shall limit discovery as reasonably practicable to complete the arbitration in the foregoing time frames. Judgment on the award
rendered by the arbitrators may be entered in any court having jurisdiction thereof. 
  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 17 

 ARTICLE 10 
  

Dispute Resolution 
  

	10.1	Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the United States and the State of Delaware, without giving effect to any
choice-of-law or conflict-of-law provision or rule (whether of the State of Delaware or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware or the United States.

  

	10.2	English Language. This Agreement is executed in the English language and no translation shall have any legal effect. 

  

	10.3	Jurisdiction and Venue. Any legal action, suit or proceeding arising under, or relating to, this Agreement, shall be brought in the federal or state courts of the State of
Delaware and each party agrees that any such action, suit or proceeding may be brought only in such courts. Each party further waives any objection to the laying of venue for any such suit, action or proceeding in such courts.

  
 ARTICLE 11 
  
 Audits 
  

	11.1	[***] and in addition within [***] months following notice to Infineon of a Qualifying License Agreement which would lead to the respective higher payment cap pursuant Sections 6.2
through 6.4, or a notice as per Article 2.3, which could lead to adjustment of payments, Rambus shall permit an independent certified public accounting firm designated by Infineon and reasonably acceptable to Rambus and subject to reasonable
confidentiality obligations to have access during normal business hours to Rambus’ facilities and premises, to allow such accounting firm to conduct an audit, at Infineon’s sole expense, of Ram bus’s books, records and agreements for
the sole purpose of verifying: (i) Rambus’ compliance with its obligations under Section 2.3; and (ii) the existence and terms of Qualifying License Agreements and whether such agreements are, or remain, in effect and are fulfilled by the
respective parties, provided that such accounting firm shall report to Infineon only whether such license agreements meet the requirements of Qualifying License Agreements and/or the amount of an adjusted quarterly payment as per Article 2.3.

  

	11.2	Rambus Audit Right. Rambus shall have the right, [***] within [***] months following each event as per Section 9.1 (Assignment) or Section 9.4 (Change of Control) to examine
and audit, at Rambus’ cost, through an independent certified public accounting firm mutually acceptable to both parties (Infineon’s approval not to be unreasonably withheld or delayed), during normal business hours, all such records as
bear upon the Payment Amount adjustments pursuant to Sections 9.1 and 9.4. Prompt adjustment shall be made by Infineon to compensate for any errors and/or omissions disclosed by such examination or audit which result in an underpayment of royalties
hereunder, together with interest thereon from the date the payment was due at an annual rate equal to twelve percent (12%) (or, if less, the maximum allowed by applicable law). 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 18 

 ARTICLE 12 
  

Miscellaneous 
  

	12.1	Entire Agreement. This Agreement constitutes the entire agreement between the parties regarding the subject matter hereof, and supersedes any and all prior negotiations,
representations, warranties, undertakings or agreements, written or oral, between the parties regarding such subject matter. 

  

	12.2	Relationship of the Parties. Nothing contained in this Agreement shall be construed as creating any association, partnership, joint venture or the relation of principal and
agent between Rambus and Infineon. Each party is acting as an independent contractor, and no party shall have the authority to bind any other party or its representatives in any way. 

  

	12.3	Confidentiality. Neither party shall disclose the terms and conditions of this Agreement to any third party without the prior written consent of the other party, except as
provided in Section 4 herein or as may be required by law or as may be reasonably necessary to enforce this Agreement. Each party may disclose the terms of this Agreement: (i) to its legal counsel or, under a suitable confidentiality agreement, to
accountants or its other professional advisors; (ii) to any governmental or regulatory authority to comply with regulatory requirements (in a redacted or sealed form to the extent possible after consulting with the other party and as determined by
the good faith advice of the applicable party’s outside counsel); (iii) to any court or governmental body or agency compelling such disclosure (after consulting with the other party and in a redacted or sealed form to the extent possible); (iv)
under a suitable confidentiality agreement, to a prospective successor (whether by way of merger, corporate reorganization, the sale of all, or substantially all, assets, or otherwise) in connection with due diligence activities relating to any such
prospective transaction; (v) as otherwise may be required by applicable securities and other law and regulation (after consulting with the other party and in a redacted or sealed form to the extent possible as determined by the good faith advice of
the applicable party’s outside counsel), including to legal and financial advisors in their capacity of advising a party in such matters; (vi) under a suitable confidentiality agreement, to banks, investors and other financing sources and their
advisors; or (vii) during the course of litigation so long as the disclosure of such terms and conditions are restricted in the same manner as is the confidential information of other litigating parties and so long as (A) the restrictions are
embodied in a court-entered protective order limiting disclosure to outside counsel and (B) the disclosing party informs the other party in writing at least ten (10) business days in advance of the disclosure and shall discuss the nature and
contents of the disclosure, in good faith, with the other party. 

  
 For the avoidance of doubt, upon execution of this Agreement, or thereafter, Rambus, in its discretion, shall be entitled to file a copy of this Agreement with the U.S. Securities and Exchange Commission (after
consulting with Infineon and in a redacted or sealed form to the extent possible as determined by the good faith advice of Rambus’ outside counsel). 
  
 In addition, Rambus shall be entitled to disclose the terms and conditions of this Agreement to independent auditors to the extent necessary to comply
with any “most favored customer” provisions of any other agreement to which Rambus is a party. 
  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 19 

	12.4	Headings. The headings of the several articles and sections are inserted for convenience of reference only and are not intended to be a part of or to affect the meaning or
interpretation of this Agreement. 

  

	12.5	Amendment. This Agreement may not be modified or amended except in a writing executed by authorized representatives of each of the parties. 

  

	12.6	Interpretation. Each party confirms that it and its respective counsel have reviewed, negotiated and adopted this Agreement as the agreement and understanding of the parties
hereto and the language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their mutual intent. Neither party shall be considered to be the drafter of this Agreement or any of its provisions for the
purpose of any statute, case law, or rule of interpretation or construction that would, or might cause, any provision to be construed against such party. 

  

	12.7	Successors and Assigns. This Agreement shall benefit, and be binding upon, the parties hereto and their respective permitted assignees, successors in interest, and
Affiliates. 

  

	12.8	Authority. Each party represents that it is fully authorized to enter into the terms and conditions of, and to execute, this Agreement. 

  

	12.9	No Third Party Beneficiaries. Unless otherwise expressly stated herein, nothing in this Agreement, express or implied, is intended to confer upon any person other than the
parties hereto or their respective permitted assignees, successors in interest, and Affiliates any rights or remedies under or by reason of this Agreement. 

  

	12.10	 Severability. If any provision of this Agreement is held to be invalid or unenforceable, the meaning of such provision shall be construed, to the extent feasible, so as
to render the provision enforceable, and if no feasible interpretation shall save such provision, it shall be severed from the remainder of this Agreement, which shall remain in full force and effect. If any provision is so severed, Rambus and
Infineon shall use their respective best efforts to negotiate, in good faith, a substitute, valid and enforceable provision or agreement, that most nearly effects the parties’ intent in entering into this Agreement. 

  

	12.11	 No Waiver. The failure of either party to enforce, at any time, any of the provisions of this Agreement shall in no way be construed as a waiver of such provisions, and
shall not be deemed in any way to affect the validity of this Agreement or any part thereof, or the right of either party to later enforce each and every such provision. No waiver of any breach of this Agreement shall be held to be a waiver of any
other or subsequent breach. 

  

	12.12	 Counterparts; Facsimile Transmission. This Agreement may be executed in multiple counterparts, each of which shall constitute an original, but all of which together
shall constitute one and the same agreement. Each party may rely on facsimile signature pages as if such facsimile pages were originals. 

  

	12.13	  Public Statements. The parties agree that no later than the first business day after the Effective Date, each shall issue the press release attached
hereto as Exhibit 12.13. Thereafter, Rambus and Infineon shall consult with each other and agree before issuing a press release or otherwise making any public statement with respect to the terms and conditions of this Agreement and shall 

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 20 

	 	 
not issue such press release or make any such public statement prior to such agreement, except that either party shall be free to repeat all or any portion
of the information contained in the press release in Exhibit 12.13 and each party shall be free to discuss the existence of the Agreement and its own reasons for entering into it. 

  

	12.14	 Non-Disparagement. Each party shall not make any public statements relating to the Disputes or this Agreement disparaging the other party or its shareholders,
directors, officers, employees or agents. 

  

	12.15	 Release of Documents. Infineon agrees that Rambus’ outside counsel of record in the California Anti-trust Litigation may immediately have access to and make use of
for purposes of the California Anti-trust Litigation all documents previously produced by Infineon to plaintiffs’ counsel for the DRAM consumer class actions currently pending in California involving DRAM. Access to and use of such documents
shall otherwise be prohibited except as permitted in the protective orders in the DRAM consumer class actions or as permitted in the protective order the trial judge has indicated will shortly be entered in California Anti-trust Litigation. If
Rambus exercises its right to such immediate access and use, then, if Rambus should seek further discovery from Infineon in The California Anti-Trust Litigation, Rambus shall pay 100 % of Infineon’s attorneys’ fees, expenses and costs
related to Infineon’s successful efforts in obtaining a protective order against any portion of future discovery Rambus may seek from Infineon. 

  
 If Rambus exercises its right to such immediate access and use, Rambus further agrees that it will not use any confidential
Infineon document at any public hearing or trial, or otherwise cause a confidential Infineon document to become public, without either the prior written consent of Infineon or on ten (10) days notice to Infineon in writing so that Infineon may file
any appropriate motions or other applications in the relevant forum to protect the confidentiality of the document. 
  
 *** 
  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 21 

 IN WITNESS WHEREOF, each of the parties hereto, by its duly authorized representative, has
executed this Agreement as of the Effective Date first written above. 
  

									
	 RAMBUS
	 	 	 	 INFINEON

			
	 Rambus, Inc.
	 	 	 	 Infineon Technologies AG

					
	 By:
	 	 /s/ Harold Hughes
	 	 	 	 By:
	 	 /s/ A.V. Zitzewitz
                    Guenther Stang

					
	 Name:
	 	 Harold Hughes
	 	 	 	 Name:
	 	 A.V. Zitzewitz
                         Guether Stang

					
	 Title:
	 	 C.E.O.
	 	 	 	 Title:
	 	 Member of Mgmt Board IFX / Corp. Counsel

					
	 Date:
	 	 3/21/2005
	 	 	 	 Date:
	 	 29.3.05

			
	 	 	 	 	 Infineon Technologies North America Corp.

					
	 	 	 	 	 	 	 By:
	 	 /s/ Miriam Martinez

					
	 	 	 	 	 	 	 Name:
	 	 Miriam Martinez

					
	 	 	 	 	 	 	 Title:
	 	 VP & CFO 

					
	 	 	 	 	 	 	 Date:
	 	 3/21/2005

			
	 	 	 	 	 Infineon Technologies Holding
 North America Inc.

					
	 	 	 	 	 	 	 By:
	 	 /s/ Miriam Martinez

					
	 	 	 	 	 	 	 Name:
	 	 Miriam Martinez

					
	 	 	 	 	 	 	 Title:
	 	 V.P. & CFO

					
	 	 	 	 	 	 	 Date:
	 	 3/21/2005

  

	[***]	Confidential treatment has been requested for the bracketed portions. The confidential redacted portion has been omitted and filed separately with the Securities and Exchange
Commission. 

  
 22 

 EXHIBIT 4.1 (c) 
  
 SETTLEMENT AGREEMENT AND MUTUAL RELEASE 
  
 This Settlement Agreement and Mutual Release (hereinafter, “Agreement”) is made and entered into by and between
Rambus Inc. (referred to herein as “Rambus”) and Siemens AG and Siemens Corporation (collectively referred to herein as “Siemens”). 
  
 WHEREAS, there is pending in the Superior Court of the State California for the City and County of San Francisco, an action filed by Rambus captioned as
Rambus Inc. v. Micron Technology, Inc. et al, Case No. 04-43 1105 (“The California Anti-trust Litigation”); 
  
 WHEREAS, Rambus desires to resolve any claims it might have against Siemens, anytime and anywhere that arise out of or are related to or are similar to
the claims alleged in The California Anti-trust Litigation, in an expeditious manner; 
  
 WHEREAS, Siemens desires to resolve any counter- or cross-claims it might have against Rambus, anytime and anywhere that arise out of or are related to or are similar to the claims alleged in The California Anti-trust
Litigation, in an expeditious manner; 
  
 WHEREAS, Siemens denies
liability to Rambus and, if Rambus pursued any claims against Siemens, Siemens would assert a number of defenses in response to such claims; 
  
 WHEREAS, Rambus denies liability to Siemens and, if Siemens pursued any counter or cross-claims against Rambus, Rambus would assert a number of defenses
in response to such claims; and 
  
 WHEREAS, Rambus and Siemens
agree that neither this Agreement nor any statement made in the negotiation thereof shall be deemed or construed to be an admission by or evidence against either party or any of its alleged co-conspirators or evidence of the truth of any allegations
in any actions, except in an action to enforce this Agreement. 
  

 NOW, THEREFORE, in consideration of the promises and covenants contained herein, and other good and
valuable consideration, the receipt and sufficiency of which is acknowledged by the parties, Rambus and Siemens agree as follows: 
  
 1. Definitions. As used in this Agreement, the following terms shall be defined as indicated: 
  

	 	(a)	“Rambus Releasees” shall mean Rambus Inc., its respective current and former direct and indirect parents, subsidiaries and affiliates, the present and former officers,
directors, employees, agents, attorneys, insurers, and representatives of each of the foregoing, and the predecessors, successors, heirs, executors, administrators and assigns of each of the foregoing. 

  

	 	(b)	“Siemens Releasees” shall mean Siemens Corporation and Siemens AG, their respective current and former direct and indirect parents, subsidiaries and affiliates, the
present and former officers, directors, employees, agents, attorneys, insurers, and representatives of each of the foregoing, and the predecessors, successors, heirs, executors, administrators and assigns of each of the foregoing.

  
 2. General Release by Rambus. Rambus hereby irrevocably
releases, acquits and forever discharges the Siemens Releasees from all manner of claims, demands, actions, suits, causes of action, whether class, individual or otherwise in nature, damages whenever or wherever incurred, liabilities of any nature
whatsoever, including without limitation costs, expenses, penalties and attorneys’ fees, known or unknown, suspected or unsuspected, asserted or unasserted, in law or in equity, which Rambus, whether directly, representatively, derivatively or
in any other capacity, ever had, now has or hereafter can, shall or may have, relating in any way to any 

  

 -2- 

 
conduct occurring prior to the effective date of this Agreement, whether now known or unknown, concerning all claims it filed in The California Anti-trust
Litigation against Siemens and any other claims, including counter or cross-claims, whether arising under state, federal, or common law, it could have asserted against Siemens relating to or arising out of the matters alleged in the Complaint in The
California Anti-trust Litigation. 
  
 3. General Release by Siemens.
Siemens hereby irrevocably releases, acquits and forever discharges the Rambus Releasees from all manner of claims, demands, actions, suits, causes of action, whether class, individual or otherwise in nature, damages whenever or wherever incurred,
liabilities of any nature whatsoever, including without limitation costs, expenses, penalties and attorneys’ fees, known or unknown, suspected or unsuspected, asserted or unasserted, in law or in equity, which Siemens, whether directly,
representatively, derivatively or in any other capacity, ever had, now has or hereafter can, shall or may have, relating in any way to any conduct occurring prior to the effective date of this Agreement, whether now known or unknown, concerning any
claims, including counter and/or cross claims, whether arising under state, federal, or common law, it could have asserted against Rambus relating to or arising out of the matters alleged in the Complaint in The California Anti-trust Litigation.

  
 4. Waiver of Cal. Civil Code § 1542. With respect to the released
claims, both Rambus and Siemens separately and expressly waive and relinquish, to the fullest extent permitted by law, any and all provisions, rights and benefits conferred by (a) § 1542 of the California Civil Code, which provides: 

 
 A general release does not extend to claims which the creditor does not
know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor. 
  

 -3- 

 and (b) any similar state, federal, or other law, rule or regulation or principle of common law limiting the
enforceability or effect of a release. Rambus and Siemens understand that they may hereafter discover facts other than or different from those that each knows or believes to be true with respect to the subject matter of the claims they release under
this Agreement, but each nonetheless hereby expressly waives and fully, finally and forever settles and releases any known or unknown, suspected or unsuspected, asserted or unasserted, contingent or non-contingent claim with respect to the claims
released herein, whether or not concealed or hidden, without regard to the subsequent discovery or existence of such other or different facts. 
  
 5. Stipulation and Order. Concurrent with the execution of this Agreement, Rambus and Siemens shall execute a stipulation and proposed order for the dismissal with
prejudice of all claims in The California Anti-Trust Litigation in the form attached hereto as Exhibit 4.5. 
  
 6. Attorneys’ Fees. Each party will pay their own respective attorneys’ fees and costs related to The California Anti-Trust Litigation and this Agreement. 
  
 7. Consideration. The consideration of Rambus’ release of claims herein is
Siemens’ mutual release if claims against Rambus. The consideration of Siemens’ release of claims herein is Rambus’ mutual release of claims against Siemens. 
  
 8. Mutual Warranties. Rambus and Siemens each represents and warrants that it has not assigned, encumbered or in any manner
transferred, in whole or in part, any claims it may have against the other or any other Releasee hereunder which otherwise would be a released claim under this Agreement. 
  
 9. No Admission of Liability. This Agreement, including all negotiations and discussions leading up to the settlement, shall not
constitute an admission of liability or other evidence of 

  

 -4- 

 
any violation of any statute or law or of any liability or wrongdoing by any person or entity, or of the truth of any of the claims or allegations by Rambus,
Siemens or any other entity. 
  
 10. Confidentiality. Neither this
Agreement, nor any of its recitals, terms or provisions, nor any of the negotiations or proceedings connected with it, nor any other action taken to carry out this Agreement, shall be offered as evidence in any pending or future civil, criminal, or
administrative action or proceedings, except in a proceeding to enforce this Agreement, or to defend against the assertion of the claims released herein, or as otherwise required by law. 
  
 11. Entire Agreement. This Agreement constitutes the entire agreement between the parties regarding the subject matter hereof, and
supersedes any and all prior negotiations, representations, warranties, undertakings or agreements, written or oral, between the parties regarding such subject matter. 
  
 12. Interpretation. Each party confirms that it and its respective counsel have reviewed, negotiated and adopted this Agreement as
the agreement and understanding of the parties hereto and the language used in this Agreement shall be deemed to be the language chosen by the parties hereto to express their mutual intent. Neither party shall be considered b be the drafter of this
Agreement or any of its provisions for the purpose of any statute, case law, or rule of interpretation or construction that would, or might cause, any provision to be construed against such party. 
  
 13. Successors and Assigns. This Agreement shall benefit, and be binding upon, the
parties hereto and their respective permitted assignees, successors in interest, parents, and Affiliates. 
  

 -5- 

 14. Authority. Each party represents that it is fully authorized to enter into the terms and conditions of, and to
execute, this Agreement. 
  
 15. Severability. If any provision of this
Agreement is held to be invalid or unenforceable, the meaning of such provision shall be construed, to the extent feasible, so as to render the provision enforceable, and if no feasible interpretation shall save such provision, it shall be severed
from the remainder of this Agreement, which shall remain in full force and effect. If any provision is so severed, Rambus and Siemens shall use their respective best efforts to negotiate, in good faith, a substitute, valid and enforceable provision
or agreement, that most nearly effects the parties’ intent in entering into this Agreement. 
  

 -6- 

 IN WITNESS WHEREOF, the parties hereto, through their duly authorized representatives, have fully
executed this Agreement on the date set forth below. 
  
 Dated:
March 18, 2005 
  

									
	 RAMBUS INC.
	 	 	 	 SIEMENS

			
	 Rambus, Inc.
	 	 	 	 Siemens AG

					
	 By:
	 	 /s/ Harold Hughes
	 	 	 	 By:
	 	 /s/ Jon R. Roellke

	 Name:
	 	 Harold Hughes
	 	 	 	 Name:
	 	 Jon R. Roellke

	 Title:
	 	 C.E.O.
	 	 	 	 Title:
	 	 Clifford Chance US LLP
 Counsel for Siemens AG

	 Date:
	 	 3/21/2005
	 	 	 	 Date:
	 	 March 18, 2005

				
	 	 	 	 	 	 	 Siemens Corporation

					
	 	 	 	 	 	 	 By:
	 	 /s/ E. Robert Lupone

	 	 	 	 	 	 	 Name:
	 	 E. Robert Lupone

	 	 	 	 	 	 	 Title:
	 	 Sr. V.P. & General Counsel

	 	 	 	 	 	 	 Date:
	 	 March 18, 2005

				
	 	 	 	 	 	 	 /s/ Gerard A. Halpin III

	 	 	 	 	 	 	 Gerard A. Halpin III

	 	 	 	 	 	 	 V.P., Treasury

	 	 	 	 	 	 	 March 18, 2005

  

 -7- 

			
	 ATTORNEY OR PARTY WITHOUT ATTORNEY (Name and Address): TELEPHONE NO.:
 Joseph W. Cotchett, #36324
                                        
                            (650) 697-6000
 Nancy L. Fineman, #124870
 Nanci E. Nishimura, #152621
 840 Malcolm Road, Suite 200
 Burlingame, California 94010
  
 ATTORNEY FOR (Name):             Plaintiff RAMBUS INC.
	  	 FOR COURT USE ONLY
  
  
 RECEIVED
 MAR 22 2005

	 Insert name of court and
name of judicial district and branch court, if any.
 SAN FRANCISCO COUNTY SUPERIOR COURT
	  	COTCHETT, PITRE, SIMON & McCARTHY
	 	 
	                     PLAINTIFF/PETITIONER:               
      RAMBUS INC.
  
 DEFENDANT/RESPONDENT:       MICRON TECHNOLOGY, INC., a
Delaware corporation, et al.
	  	 
	 REQUEST FOR DISMISSAL
  ̈ Personal Injury, Property
Damage, or Wrongful Death
                  ̈ Motor Vehicle              ̈ Other
  ̈ Family Law
  ̈ Eminent Domain
 x Other
(specify): Antitrust
	  	 Case Number:
  
 04-431105

	 
	— A conformed copy
will not be returned by the clerk unless a method of return is provided with the document. —
	
	1. TO THE CLERK: Please dismiss this action as follows:
	 a. (1) x With prejudice
(2)  ̈ Without prejudice
 b. (1)  ̈ Complaint        (2)  ̈ Petition
     (3)  ̈ Cross-complaint filed by (name): on (date):
     (4)  ̈ Cross-complaint filed by (name): on (date):

	     (5)  ̈ Entire action of all parties and all causes of action
     (6) x Other (specify):* Infineon
Technologies AG, Infineon Technologies North America Corp., Siemens
 Corporation and Siemens AG only; each party to bear its own fees and
costs
 Date: March 21, 2005

					
			
	 Nanci E. Nishimura
	 	 	 	Ø /s/ Nanci E. Nishimura
	(TYPE OR PRINT NAME OF x ATTORNEY  ̈ PARTY WITHOUT ATTORNEY)	 	 	 	 Attorney or party attorney for: Rambus Inc.
 (see
attached for additional attorneys)

					
			
	 *  If dismissal requested is of specified parties only, of specified causes of action only, or of specified cross-complaints only,
so state and identify the parties, causes of action, or cross-complaints to be dismissed.
	 	 x Plaintiff/Petitioner
  ̈ Cross-complaint
	 	 ̈ Defendant/Respondent

  
 2.     TO THE
CLERK: Consent to the above dismissal is hereby given.** 
 Date: 

					
	**See attached for signatures**	 	 	 	  
	 	 	 	 	 (SIGNATURE)

	(TYPE OR PRINT NAME OF  ̈ ATTORNEY  ̈ PARTY WITHOUT ATTORNEY)	 	 	 	 Attorney or party attorney for:

					
			
	 *  If a cross-complaint - or Response (Family Law) seeking affirmative relief - is on file, the attorney for cross-complainant
(respondent) must sign this consent of required by Code of Civil Procedure section 581 (i) or (j).
	 	  ̈ Plaintiff/Petitioner
  ̈ Cross-complaint
	 	 ̈ Defendant/Respondent

  
 (To be completed by clerk)

 3.  ̈ Dismissal entered as requested on (date):

 4.  ̈ Dismissal entered on (date): as to only
(name): 
 5.  ̈ Dismissal not entered as requested
for the following reasons (specify): 
 6.  ̈ a.
Attorney or party without attorney notified on (date): 
          b. Attorney or party without attorney not
notified. Filing party failed to provide 
           ̈ a copy to conform               ̈ means to return conformed copy 
  

					
	Date:	 	 	 	Clerk, by
                                        ,
Deputy

  

					
	 Form Adopted by the
 Judicial Counsel of California
 982(a)(5) [REV. January 1, 1997]
 Mandatory Form
	  	REQUEST FOR DISMISSAL	  	 Code of Civil Procedure, §581 et. seq.
 Cal. Rules of Court, rules 383 1233
  
 FILE COPY

  

 ADDITIONAL COUNSEL FOR PLAINTIFF RAMBUS INC.: 
  

									
	 Dated: March 21, 2005
	 	 	 	 MUNGER, TOLLES & OLSON LLP

					
	 	 	 	 	 	 	By:	 	 /s/ Gregory P. Stone@

	 	 	 	 	 	 	 	 	 GREGORY P. STONE, #78329

	 	 	 	 	 	 	 	 	 BRADLEY S. PHILLIPS, #85263

	 	 	 	 	 	 	 	 	 STEVEN M. PERRY, #1 06 154

	 	 	 	 	 	 	 	 	 SHONT E. MILLER, #210801

	 	 	 	 	 	 	 	 	 355 South Grand Avenue, 35th Floor

	 	 	 	 	 	 	 	 	 Los Angeles, CA 90071-1560

	 	 	 	 	 	 	 	 	 Tel: (213) 683-9100

	 	 	 	 	 	 	 	 	 Fax: (213) 687-3702

					
	 	 	 	 	 	 	 	 	 Attorneys for Plaintiff

	 	 	 	 	 	 	 	 	 RAMBUS INC.

  

	2.	TO THE CLERK: Consent to the above dismissal is hereby given. 

  

									
	 Dated: March 21, 2005
	 	 	 	 KIRKLAND & ELLIS LLP

					
	 	 	 	 	 	 	By:	 	 /s/ Sarretta C. McDonough/BRO

	 	 	 	 	 	 	 	 	 SARRETTA C. MCDONOUGH, #192858

	 	 	 	 	 	 	 	 	 777 South Figueroa Street

	 	 	 	 	 	 	 	 	 Los Angeles, CA 90017

	 	 	 	 	 	 	 	 	 Tel: (213) 680-8400

	 	 	 	 	 	 	 	 	 Fax: (213) 680-8500

					
	 	 	 	 	 	 	 	 	 Attorneys for Defendants

	 	 	 	 	 	 	 	 	 INFINEON TECHNOLOGIES NORTH

	 	 	 	 	 	 	 	 	 AMERICA CORP. and INFINEON

	 	 	 	 	 	 	 	 	 TECHNOLOGIES AG

			
	 Dated: March 21, 2005
	 	 	 	 CLIFFORD CHANCE

					
	 	 	 	 	 	 	 By:
	 	 /s/ Jon R. Roellke/BRO

	 	 	 	 	 	 	 	 	 NANCY RABER

	 	 	 	 	 	 	 	 	 JAMES WEIDNER

	 	 	 	 	 	 	 	 	 JON R. ROELLKE

	 	 	 	 	 	 	 	 	 2001 K Street, N.W.

	 	 	 	 	 	 	 	 	 Washington, DC 20006-1001

	 	 	 	 	 	 	 	 	 Tel: (202) 912-5000

	 	 	 	 	 	 	 	 	 Fax: (202) 912-6000

	 	 	 	 	 	 	 	 	 Attorneys for Defendants

	 	 	 	 	 	 	 	 	 SIEMENS CORPORATION and

	 	 	 	 	 	 	 	 	 SIEMENS AG

  

 -1- 

 Request for Dismissal 

 IN THE UNITED STATES DISTRICT COURT 
 FOR THE EASTERN DISTRICT OF VIRGINIA 
 Richmond Division 
  

					
	 RAMBUS INC.
  
                                        
     Plaintiff,
	 	 	 	 FILED
 MAR 21, 2005
 CLERK, U.S. DISTRICT COURT
 RICHMOND, VA

	  
 v.
  
 INFINEON TECHNOLOGIES AG, et al.
  
                                        
     Defendants.
	 	  
 Civil Action No.: 3:00
CV524
	 	 

  
 STIPULATION OF
DISMISSAL WITH PREJUDICE 
  
 Pursuant to Federal Rule of Civil
Procedure 41(a)(I)(ii), Plaintiff and Counterclaim- 
  
 Defendant Rambus Inc.
(“Rambus”) and Defendants and Counterclaimants Infineon 
  
 Technologies
AG, Infineon Technologies North America Corp., Infineon Technologies, Inc., 
  
 Infineon Technologies Holding North America Inc. a/k/a Infineon Technologies Holding 
  
 North America Corp., and Infineon Technologies Corp. (collectively “Infineon”), by their 
  
 undersigned attorneys, hereby stipulate to the dismissal with prejudice of this action, 
  
 including, without limitation, all claims and counterclaims alleged by either Rambus or 
  
 Infineon in this action at any time (including any claims and counterclaims previously

  
 dismissed either voluntarily or involuntarily). 
  

 It is further stipulated that each party shall bear its own costs and attorneys’ fees. 

 

					
	 DATED: March 21, 2005
	 	 	 	 DATED: March 21, 2005

			
	 /s/ B.C. Riopelle
	 	 	 	 /s/ R.B. Hill

	 Brian C. Riopelle (VSB No. 36454)
	 	 	 	 Michael W. Smith (VSB No. 01125)

	 Robert M. Tyler (VSB No. 37861)
	 	 	 	 Craig T. Merritt (VSB No. 20281)

	 McGUIRE WOODS LLP
	 	 	 	 R. Braxton Hill, IV (VSB No. 41539)

	 One James Center
	 	 	 	 CHRISTIAN & BARTON, LLP

	 901 East Cary Street
	 	 	 	 909 East Main Street, Suite 1200

	 Richmond, Virginia 23219-4030
	 	 	 	 Richmond, Virginia 23219

	 (804) 775-1000
	 	 	 	 (804) 697-4112

			
	 OF COUNSEL:
	 	 	 	 OF COUNSEL:

	 John M. Desmarais
	 	 	 	 Gregory P. Stone

	 Gregory S. Arovas
	 	 	 	 Steven M. Perry

	 Michael P. Stadnick
	 	 	 	 Peter A. Detre

	 KIRKLAND & ELLIS LLP
	 	 	 	 MUNGER, TOLLES & OLSEN LLP

	 Citigroup Center
	 	 	 	 355 South Grand Avenue, 35th Floor

	 153 East 53rd Street
	 	 	 	 Los Angeles, California 90071-1560

	 New York, New York 10022
	 	 	 	 (213) 683-9100

	 (212) 446-4800
	 	 	 	 
	 ATTORNEY FOR DEFENDANTS
	 	 	 	 ATTORNEY FOR PLAINTIFF

  
 710237 
  

 -2- 

 James J. Elacqua (SBN 187897) 
 E-mail: JElacqua@dbllp.com 
 Jeannine Yoo Sano (SBN 174190) 
 E-mail: JSano@dbllp.com 
 DEWEY BALLANTINE LLP 
 1950
University Avenue, Suite 500 
 East Palo Alto, California 94303-2225 
 Telephone: (650) 845-7000 
 Facsimile: (650) 845-7333 
  
 Kevin S. Kudlac (admitted pro hac vice) 
 E-mail: KKudlac@dbllp.com

 Pierre J. Hubert (admitted pro hac vice) 
 E-mail:
PHubert@dbllp.com 
 Brian K. Erickson (admitted pro hac vice) 
 E-mail: BErickson@dbllp.com 
 DEWEY BALLANTINE LLP 
 401
Congress Avenue, Suite 3200 
 Austin, Texas 78701 
 Telephone:
(512) 226-0300 
 Facsimile: (512) 226-0333 
  
 Attorneys for Plaintiff 
 Rambus Inc. 
 UNITED STATES DISTRICT COURT 
 NORTHERN DISTRICT OF CALIFORNIA 
 SAN FRANCISCO DIVISION 
  

			
	 RAMBUS INC.,
  
 Plaintiff,
  
 VS.
  
 HYNIX SEMICONDUCTOR INC., HYNIX
SEMICONDUCTOR AMERICA INC., HYNIX SEMICONDUCTOR MANUFACTURING
AMERICA INC.,
  
 INFINEON TECHNOLOGIES AG,
INFINEON TECHNOLOGIES NORTH
AMERICA CORP.,
  
 NANYA TECHNOLOGY CORPORATION,
NANYA TECHNOLOGY CORPORATION
U.S.A.,
  
 INOTERA MEMORIES, INC.,
  
 Defendants.
	 	 Case No. C 05 00334 EDL
  
 STIPULATED DISMISSAL WITH
PREJUDICE (FED. R. CIV. P.
41(a)(1)(i) OF ALL CLAIMS AGAINST
DEFENDANTS INFINEON
TECHNOLOGIES AG AND INFINEON
TECHNOLOGIES
NORTH AMERICA
CORP.

  

			
	 	  	 Stipulated Dismissal With
 Prejudice of Defendants Infineon
 Technologies AG and Infineon
 Technologies North America
 Corp. No. C 05 00334
EDL

  
 -4- 

  
 Plaintiff Rambus Inc. hereby
dismisses with prejudice all claims asserted by Rambus against Defendants Infineon Technologies AG and Infineon Technologies North America Corp., 
 with each
party to bear its own costs and attorney fees. 
  
 Dated: March 22, 2005

  

			
	 Respectfully submitted,

	
	DEWEY BALLANTINE LLP
		
	By	 	 /s/ Jeannine Yoo Sano

	 	 	 Jeannine Yoo Sano

	 	 	 Attorneys for Plaintiff Rambus Inc.

  
 -2- 

 

  

			
	 	  	 Stipulated Dismissal With
 Prejudice of Defendants Infineon
 Technologies AG and Infineon
 Technologies North America
 Corp. No. C 05 00334
EDL

 Exhibit 5.1 
  
 District Web PACER (v2.4) 
  
 [SELECT EVENTS FROM THE DOCKET REPORT FOR CASE: 3:00cv00524 
 FOR THE PERIOD 03/01/2005 to 03/18/2005] 
  

					
	3/1/05	  	1044	  	 (CORRECTED VERSION) PROPOSED FINDINGS OF FACT regarding
 Rambus’ Unclean Hands and Spoliation of Evidence Infineon
 (cgar)

			
	3/1/05	  	1045	  	 ORDER denying [1029-1] motion for immediate discovery
 regarding the “JRA” Group and Regarding Infineon’s failure
 to provide discovery regarding the JRA Group and its
 analysis of Rambus patents by Rambus, Inc. ( signed by Judge Robert E. Payne ) Copies Mailed: yes [EOD Date: 3/1/05] (cgar)

			
	3/1/05	  	1046	  	 ORDER Infineon’s objections to trial exhibits designated by
 Rambus in connection with its defense to Infineon’s monopolization counterclaim: PTX 7272; PTX 7275-7297; PTX 7300; PTX 7452-7438; PTX 7985; and PTX 8428 are SUSTAINED (
 signed by Judge Robert E. Payne ) Copies Mailed: yes [EOD
 Date: 3/1/05] (cgar)

			
	3/1/05	  	1047	  	 Minute entry: Payne, J., Josett Whalen, For The Record,
 Inc., Court Reporter. (1-800-921-5555). Closing Arguments had from Evidentiary Hearing on Spoliation/Unclean Hands.
 The Court ruled that Infineon
has proved that Rambus had
 Unclean Hands and also proved the Spoliation issue. An
 Opinion will enter dismissing the Patent Infringement Claims. Defendant’s Motion to Dismiss the Monopolization Claimheard; arguments had. Motion granted. (snea)
 [Edit date 03/02/05]

			
	3/1/05	  	—  	  	 Status Conference set at 2:00 3/2/05 before Judge Robert
 E. Payne (snea)

			
	3/2/05	  	1048	  	 Minute entry:Payne, J., Diane Daffron, OCR. Parties by
 counsel. Matter came on for a Status Conference.
 Defendant’s Motion To Dismiss the 17200 Claim Without
 Prejudice heard. Rambus’s Motion to Dismiss the 17200 Claim
 With
Prejudice heard. Arguments had. The Court will grant
 the Defendant’s Motion and the 17200 Claim will be
 dismissed without prejudice. An Order will enter after the
 final judgment on
other issues is entered. (snea)

  

							
	 Docket as of March 17, 2005 7:18 pm
	  	Page 150	  	 	  	 
				
	 Proceedings include all events.
 3:00cv524 Rambus, Inc., et a1 v. Infineon, et a1
	  	 	  	JURY	  	 
				
	 	  	 	  	 	  	PROTO

  

					
	3/3/05	  	1049	  	 NOTICE of Lodging of Demonstratives and Exhibits used
 during its Unclean Hands Closing Argument by Rambus, Inc.;
 (6 Black binders labeled “Exhibits” and 1 black binders
 (demonstrative) in 2 banker boxes) (cgar)
 [Entry date
03/04/05]

			
	3/4/05	  	1050	  	 TRANSCRIPT of conference call before the Honorable Robert
 E. Payne for date of 03/03/05 (cgar)

			
	3/16/05	  	1051	  	 TRANSCRIPT of status conference before the Honorable Robert
 E. Payne for date of 03/02/05 (cgar) [Entry date 03/17/05]

  
 [END OF DOCKET: 3:00cv524] 

 

	
	 

 PACER Service Center 
 Transaction Receipt 
  
 03/18/2005
11:51:24 
  

					
	 PACER Login: cb0033
	  	 Client Code:
	  	 03570.00001

	 Description: docket report
	  	 Search Criteria:
	  	 3:00cv00524

	 Billable Pages:
                    2
	  	 Cost: 0.16
	  	 

  

	
	 

  

 -2- 

 EXHIBIT 12.13 
  
 Infineon Technologies and Rambus Conclude Broad Licensing Agreement 
  
 Agreement also settles all existing claims between the two companies 
  
 Munich, Germany and Los Altos, California: March 21, 2005 6 AM California – Infineon (NYSE and FSE: IFX) 
 and Rambus (NASDAQ: RMBS) announced that they have reached an 
 agreement
settling all claims between them and licensing the Rambus patent portfolio for use in 
 current and future Infineon products. 
  
 Rambus has granted to Infineon a worldwide license to existing and future Rambus patents and

 patent applications for use in Infineon memory products. In exchange, Infineon will pay a 
 quarterly license fee of US $5.85 million starting by November 15, 2005 through November 15, 2007. After November 15, 
 2007,
and only if Rambus enters into additional specified licensing 
 agreements with certain other DRAM manufacturers, Infineon will make additional quarterly

 payments which may accumulate up to a maximum of an additional $100 million. 
  
 The agreement also provides Infineon an option for acquiring certain other licenses. All licenses 
 provide for Infineon to be treated as a “most-favored customer” of Rambus. 
  
 Infineon has simultaneously granted to Rambus a fully-paid perpetual license for memory 
 interfaces. 
  
 In addition to the licenses, the two companies have agreed to the immediate dismissal of all 
 pending litigation and have
released each other from all existing legal claims. 
  
 About Infineon 

 
 Infineon Technologies AG, Munich, Germany, offers semiconductor and system solutions for

 automotive, industrial and multimarket sectors, for applications in communication, as well as 
 memory products. With a global presence, Infineon operates through its subsidiaries in the US 
 from San Jose, CA, in the
Asia-Pacific region from Singapore and in Japan from Tokyo. In fiscal 
 year 2004 (ending September), the company achieved sales of Euro 7.19 billion with
about 
 35,600 employees worldwide. Infineon is listed on the DAX index of the Frankfurt Stock 
 Exchange and on the New York Stock Exchange (ticker symbol: IFX). Further information is available at www.infineon.com. 
  

About Rambus Inc. Rambus is one of the world’s premier technology licensing companies 
 specializing in the invention and design of high-speed chip interfaces. Since its founding in 1990, 
 the company’s
innovations, breakthrough technologies and integration expertise have helped 
 industry-leading chip and system companies solve their most challenging and
complex I/0 
 problems and bring their products to market. Rambus’s interface solutions can be found in numerous 
 computing, consumer, and communications products and applications. Rambus is headquartered in Los Altos, 
 Calif., with regional offices in Chapel Hill, North Carolina, Taipei, 
 Taiwan and Tokyo, Japan. Additional information is
available at www.rambus.com.Notice of Stock Option Award

 EXHIBIT 10(T) 
  
 OXIS INTERNATIONAL, INC. 2003 STOCK INCENTIVE PLAN 
  
 NOTICE OF STOCK OPTION AWARD 
  

			
	 Optionee’s Name and Address:
	  	 Steven T. Guillen
 334 Blackfield Drive
 Tiburon, California 94920

  
 You (the
“Optionee”) have been granted an option to purchase Common Shares, subject to the terms and conditions of this Notice of Stock Option Award (the “Notice”), the OXIS International, Inc. 2003 Stock Incentive Plan, as amended from
time to time (the “Plan”) and the Stock Option Agreement (the “Option Agreement”) attached hereto, as follows. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Notice and
the Option Agreement. 
  

			
	Award Number	  	__________________________________________
		
	Date of Award	  	February 28, 2005
		
	Vesting Commencement Date	  	February 28, 2005
		
	Exercise Price per Share	  	$0.40
		
	Total Number of Common Shares Subject to the Option (the “Shares”)	  	500,000
		
	Total Exercise Price	  	$200,000
		
	Type of Option:	  	XXX     ISO
		
	 	  	             NSO
		
	Expiration Date:	  	February 28, 2015
		
	Post-Termination Exercise Period:	  	Except as provided below, from the effective date of the Termination to the earlier of one (1) year after Termination or the Expiration Date

  
 Vesting Schedule: 
  
 1. Subject to the
Optionee’s continued Service and other provisions set forth in this Notice, the Plan and the Option Agreement, the Option may be exercised, in whole or in part, in accordance with the following schedule: 
  
 25% of the Shares subject to the Option are vested as of the Vesting
Commencement Date; 25% of the Shares subject to the Option shall vest on the first anniversary of the Vesting Commencement Date; 25% of the Shares subject to the Option shall vest on the second anniversary of the Vesting Commencement Date; and the
final 25% of the Shares subject to the Option shall vest on the third anniversary of the Vesting Commencement Date. 
  

 1 

 2. During any authorized leave of absence, the vesting of the Option as provided in this schedule shall
be suspended after the leave of absence exceeds a period of ninety (90) days. Vesting of the Option shall resume upon the Optionee’s termination of the leave of absence and return to service to the Company or the Parent, Subsidiary or Affiliate
of the Company. The Vesting Schedule of the Option set forth in Section 1 above shall be extended by the length of the suspension. 
  
 3. In the event of a Change in Control as described below, any Shares subject to the Option not vested at the time of Change in Control shall immediately
and automatically, as of the effective date of such Change in Control, vest and become exercisable for the period ending on the Expiration Date. In addition, the Shares subject to the Option shall vest immediately in the event that the Optionee
terminates his employment with “Good Reason” as defined below. 
  
 4. For purposes of this Option Agreement, “Change in Control” shall mean any of the following transactions or events effecting a change in ownership or control of the Company: 
  
 (a) a merger, consolidation, or reorganization approved by
the Company’s stockholders, unless securities representing more than 50% of the total combined voting power of the voting securities of the successor company are immediately thereafter beneficially owned, directly or indirectly, and in
substantially the same proportion, by the persons who beneficially owned the Company’s outstanding voting securities immediately prior to such transaction; 
  
 (b) any stockholder-approved transfer or any other disposition of all of the Company’s assets;

  
 (c) the acquisition, directly or indirectly,
by any person or related group of persons (other than the Company or a person that directly or indirectly controls, is controlled by, or is under common control with, the Company), of beneficial ownership (within the meaning of Rule 13d of the
Securities Exchange Act of 1934, as amended) of securities possessing more than 50% of the total combined voting power of the Company’s outstanding securities pursuant to a tender or exchange offer made directly to the Company’s
stockholders; or 
  
 (d) a change in the
composition of the Board of Directors (the “Board”) of the Company such that (a) five (5) or more Board members resign or are otherwise removed as Board members within any period of six (6) consecutive months or less; or (b) five (5) or
more Board members opt not to stand for re-election to the Board within any period of six (6) consecutive months or less; or (c) any combination of the foregoing subsections 4(a) and 4(b) above occurs such that five (5) or more Board member
positions are affected by a combination of resignations/removals, the option not to stand for re-election, or the increase/decrease of the authorized number of Board members within any period of six (6) consecutive months or less. As an example of
the foregoing, and for illustrative purposes only, in the event that two (2) Board members resign and five (5) Board members opt not to stand for re-election, all of which occur within any period of six (6) months or less, a Change of Control will
be deemed to have occurred. 
  
 5. Subject to the provisions of
subsection 5(b) below and the other terms and conditions of this Option Agreement, in the event (i) the Company terminates Optionee’s employment 

  

 2 

 
without “Cause” (as defined below), (ii) within twelve months after a Change of Control (as defined above), the Optionee terminates his employment
with “Good Reason” (as defined below) or (iii) the Optionee’s employment terminates as a result of the Optionee’s death or disability (any of the foregoing being a “Severance Termination”), the following provisions
shall apply: 
  
 (a) Upon a Severance
Termination, the Optionee shall be able to exercise any options which have vested on or before the termination date until the later of (i) the fifth anniversary of the Vesting Commencement Date or (ii) the third anniversary of the date of
termination; provided that, in all circumstances, this Option Agreement shall expire on the Expiration Date. 
  
 (b) The effectiveness of the provisions of subsection 5(a) above shall be contingent upon (i) the Optionee’s execution of a waiver
and release of all claims against the Company substantially in the form as approved by the Board (however, such waiver and release form shall not materially modify or alter the terms of this Option Agreement, nor shall such form place any
conditions, restrictions or approvals, such as Board approvals or otherwise, on Optionee’s right to receive any benefit of any sort pursuant to this Option Agreement) and expiration of the seven-day revocation period referred to in such
release, (ii) the Optionee’s not engaging in any competition with the Company during the period of his employment by the Company (iii) the Optionee’s “not engaging in any solicitation” during the period of his employment by the
Company. 
  
 (c) In this Option Agreement, the
term “Cause” means: (a) the Optionee’s failure to adhere to any written policy of the Company if the Optionee has been given a reasonable opportunity to comply with such policy and cure the Optionee’s failure to comply (which
reasonable opportunity to cure must be granted for a period of ten (10) days); (b) the willful and continued failure by the Optionee, if not cured within ten (10) days after receipt by the Optionee of written notice from the Company reasonably
detailing the matters to be cured, to substantially perform his material duties and responsibilities with the Company under this Agreement as directed by the Board (other than any such failure resulting from his incapacity due to physical or mental
illness); (c) the Optionee’s appropriation (or attempted appropriation) of a business opportunity of the Company, including attempting to secure or securing any personal profit in connection with any transaction entered into on behalf of the
Company; (d) the Optionee’s misappropriation (or attempted misappropriation) of any of the Company’s funds or property (including without limitation trade secrets and other intellectual property); (e) Optionee committing a material breach
of the employment letter agreement dated February 28, 2005 (“employment letter agreement”), or the non disclosure and inventions assignment agreement (the “NDA”) the Optionee signed in connection with the commencement of his
employment with the Company, which breach is not cured within ten (10) days after written notice to Optionee from the Company; or (f) the Optionee’s conviction of, or the Optionee’s entering of a guilty plea or pleas of no contest with
respect to, a felony or the equivalent thereof. 
  
 (d) In this Option Agreement, the term “Good Reason” means (i) the Optionee’s assignment (without the Optionee’s consent) to a position, title, responsibilities, or duties of a materially lesser status or degree of
responsibility than the position, responsibilities, or duties of Chief Executive Officer of the Company (a change in title of President does not constitute “Good Reason”); (ii) the relocation (without the Optionee’s consent) of the

  

 3 

 
Company’s principal office at which the Optionee is principally employed to a location which is more than 30 miles from the location of the
Company’s principal offices on the date of this Option Agreement; provided, however, that the Optionee must have given the written notice to the Company that the Optionee believes he has the right to terminate employment for Good Reason,
specifying in reasonable detail the events comprising the Good Reason, and the Company fails to eliminate the Good Reason within fifteen (15) days after receipt of the notice. 
  
 In the event that any term of this Notice is inconsistent with the attached Stock Option Agreement, the Plan or the
Optionee’s employment letter agreement dated February 28, 2005, the terms of this Notice shall control. 
  
 IN WITNESS WHEREOF, the Company and the Optionee have executed this Notice and agree that the Option is to be governed by the terms and conditions of this
Notice, the Plan, and the Option Agreement. 
  

			
	 OXIS International, Inc.,
 a Delaware corporation

		
	 By:
	 	 /s/ S. Colin Neill

	 Title:
	 	 Secretary

  
 THE OPTIONEE ACKNOWLEDGES THAT
THE OPTIONEE HAS HAD THE OPPORTUNITY TO CONSULT LEGAL COUNSEL CONCERNING THIS OPTION AGREEMENT, THAT THE OPTIONEE HAS READ AND UNDERSTANDS THE OPTION AGREEMENT, THAT THE OPTIONEE IS FULLY AWARE OF ITS LEGAL EFFECT, AND THAT THE OPTIONEE HAS ENTERED
INTO IT FREELY BASED ON THE OPTIONEE’S OWN JUDGMENT AND NOT ON ANY REPRESENTATIONS OR PROMISES OTHER THAN THOSE CONTAINED IN THIS OPTION AGREEMENT. 
  
 THE OPTIONEE ACKNOWLEDGES AND AGREES THAT THE SHARES SUBJECT TO THE OPTION SHALL VEST, IF AT ALL, ONLY DURING THE PERIOD OF THE OPTIONEE’S SERVICE. THE OPTIONEE
FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS NOTICE, THE OPTION AGREEMENT, OR THE PLAN SHALL CONFER UPON THE OPTIONEE ANY RIGHT WITH RESPECT TO FUTURE AWARDS OR CONTINUATION OF THE OPTIONEE’S SERVICE, NOR SHALL IT INTERFERE IN ANY WAY
WITH THE OPTIONEE’S RIGHT OR THE RIGHT OF THE COMPANY OR ANY PARENT, SUBSIDIARY OR AFFILIATE OF THE COMPANY TO WHICH THE OPTIONEE PROVIDES SERVICES TO TERMINATE THE OPTIONEE’S SERVICE, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT NOTICE. THE
OPTIONEE ACKNOWLEDGES THAT UNLESS THE OPTIONEE’S EMPLOYMENT WITH THE COMPANY TO THE CONTRARY, THE OPTIONEE’S STATUS IS AT WILL. 
  
 THE SALE OF THE SECURITIES WHICH ARE THE SUBJECT OF THIS AGREEMENT HAS NOT BEEN QUALIFIED WITH THE COMMISSIONER OF CORPORATIONS OF THE STATE OF CALIFORNIA, AND THE
ISSUANCE OF SUCH SECURITIES OR THE PAYMENT OR RECEIPT OF ANY PART OF THE CONSIDERATION THEREFOR PRIOR TO SUCH QUALIFICATION IS UNLAWFUL, UNLESS THE SALE OF SECURITIES IS 

  

 4 

 
EXEMPT FROM THE QUALIFICATION BY SECTION 25100, 25102 OR 25105 OF THE CALIFORNIA CORPORATIONS CODE. THE RIGHTS OF ALL PARTIES TO THIS AGREEMENT ARE EXPRESSLY
CONDITIONED UPON SUCH QUALIFICATION BEING OBTAINED, UNLESS THE SALE IS SO EXEMPT. THE OPTIONEE IS ACQUIRING THIS OPTION AND ANY SHARES TO BE RECEIVED BY HIM ARE BEING, AND WILL BE, ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO THE SALE OR
DISTRIBUTION OF ANY PART THEREOF. 
  
 The Optionee acknowledges
receipt of a copy of the Plan and the Option Agreement, and represents that he is familiar with the terms and provisions thereof, and hereby accepts the Option subject to all of the terms and provisions hereof and thereof. The Optionee has reviewed
this Notice, the Plan, and the Option Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Notice, and fully understands all provisions of this Notice, the Plan and the Option Agreement. The
Optionee hereby agrees that all questions of interpretation and administration relating to this Notice, the Plan and the Option Agreement shall be resolved by the Committee in accordance with Section 13 of the Option Agreement. The Optionee further
agrees to the venue selection and waiver of a jury trial in accordance with Section 14 of the Option Agreement. The Optionee further agrees to notify the Company upon any change in the residence address indicated in this Notice. 
  

									
			
	Dated: February 28, 2005	 	 Signed: 
	 	 /s/ Steven T. Guillen

	 	 	 	 	 	 	 	 	 Optionee

  

 5 

  
 Award Number:
                     
  
 OXIS INTERNATIONAL, INC. 2003 STOCK INCENTIVE PLAN 
  
 STOCK OPTION AGREEMENT 
  
 1. Grant of Option. OXIS International, Inc., a Delaware corporation (the “Company”), hereby grants to the Optionee (the
“Optionee”) named in the Notice of Stock Option Award (the “Notice”), an option (the “Option”) to purchase the Total Number of Common Shares subject to the Option (the “Shares”) set forth in the Notice, at the
Exercise Price per Share set forth in the Notice (the “Exercise Price”) subject to the terms and provisions of the Notice, this Stock Option Agreement (the “Option Agreement”) and the Company’s 2003 Stock Incentive Plan, as
amended from time to time (the “Plan”) or in the Notice, which are incorporated herein by reference. Unless otherwise defined herein, the terms defined in the Plan shall have the same defined meanings in this Option Agreement. 

 
 If designated in the Notice as an ISO, the Option is intended to qualify
as an ISO as defined in Section 422 of the Code. However, notwithstanding such designation, to the extent that the aggregate Fair Market Value of Shares subject to Options designated as ISOs which become exercisable for the first time by the
Optionee during any calendar year (under all plans of the Company or any Parent or Subsidiary of the Company) exceeds $100,000, such excess Options, to the extent of the Shares covered thereby in excess of the foregoing limitation, shall be treated
as NSOs. For this purpose, ISOs shall be taken into account in the order in which they were granted, and the Fair Market Value of the Shares shall be determined as of the date the Option with respect to such Shares is awarded. 
  
 2. Exercise of Option. 
  
 (a) Right to Exercise. The Option shall be
exercisable during its term in accordance with the Vesting Schedule set out in the Notice and with the applicable provisions of the Plan and this Option Agreement. The Option shall be subject to the provisions of Section 2(d) of the Option
Agreement relating to the exercisability or termination of the Option in the event of a Change in Control. The Optionee shall be subject to reasonable limitations on the number of requested exercises during any monthly or weekly period as determined
by the Committee. In no event shall the Company issue fractional Shares. 
  
 (b) Method of Exercise. The Option shall be exercisable by delivery of an exercise notice (a form of which is attached as Exhibit A) or by such other procedure as specified from time to time by the Committee
which shall state the election to exercise the Option, the whole number of Shares in respect of which the Option is being exercised, and such other provisions as may be required by the Committee. The exercise notice shall be delivered in person, by
certified mail, or by such other method (including electronic transmission) as determined from time to time by the Committee to the Company accompanied by payment of the Exercise Price. The Option shall be deemed to be exercised upon receipt by the
Company of such notice accompanied by the Exercise Price, which, to the extent selected, shall be deemed to 

  

 1 

 
be satisfied by use of the broker-dealer sale and remittance procedure to pay the Exercise Price provided in Section 3(d) below. 
  
 (c) Taxes. No Shares will be delivered to the
Optionee or other person pursuant to the exercise of the Option until the Optionee or other person has made arrangements acceptable to the Committee for the satisfaction of applicable income tax and employment tax withholding obligations, including,
without limitation, such other tax obligations of the Optionee incident to the receipt of Shares or the disqualifying disposition of Shares received on exercise of an ISO. Upon exercise of the Option, the Company or the Optionee’s employer may
offset or withhold (from any amount owed by the Company or the Optionee’s employer to the Optionee) or collect from the Optionee or other person an amount sufficient to satisfy such tax withholding obligations. 
  
 (d) Change in Control. This Option shall not
terminate in connection with a Change in Control (as defined in the Notice). In the event the Company shall be acquired pursuant to a merger, acquisition, stock purchase, reorganization or similar transaction, this Option shall be assumed by the
acquiring entity with appropriate adjustments to the number and type of securities of the successor entity or its parent subject to the Option and the exercise or purchase price thereof which at least preserves the value of the Option existing at
the time of the Change in Control as determined in accordance with the instruments evidencing the agreement to assume the Option. 
  
 3. Method of Payment. Payment of the Exercise Price shall be made by any of the following, or a combination thereof, at the election of the
Optionee; provided, however, that such exercise method does not then violate any applicable law and, provided further, that the portion of the Exercise Price equal to the par value of the Shares must be paid in cash or other legal consideration
permitted by the Delaware General Corporation Law: 
  
 (a) cash; 
  
 (b) check; 
  
 (c) surrender of Shares or delivery of a properly executed
form of attestation of ownership of Shares as the Committee may require which have a Fair Market Value on the date of surrender or attestation equal to the aggregate Exercise Price of the Shares as to which the Option is being exercised, provided,
however, that Shares acquired under the Plan or any other equity compensation plan or agreement of the Company must have been held by the Optionee for a period of more than six (6) months (and not used for another option exercise by attestation
during such period); or 
  
 (d) payment
through a broker-dealer sale and remittance procedure pursuant to which the Optionee (i) shall provide written instructions to a Company-designated brokerage firm to effect the immediate sale of some or all of the purchased Shares and remit to the
Company sufficient funds to cover the aggregate exercise price payable for the purchased Shares and (ii) shall provide written directives to the Company to deliver the certificates for the purchased Shares directly to such brokerage firm in order to
complete the sale transaction. 
  

 2 

 4. Restrictions on Exercise. The Option may not be exercised if the issuance of the Shares subject
to the Option upon such exercise would constitute a violation of any applicable laws. 
  
 5. Termination or Change of Service. In the event of the Optionee’s change in status from Employee, Outside Director or Consultant to any other status of Employee, Outside Director or Consultant, the
Option shall remain in effect and vesting of the Option shall continue only to the extent determined by the Committee as of such change in status; provided, however, that with respect to any ISO that shall remain in effect after a change in status
from Employee to Outside Director or Consultant, such ISO shall cease to be treated as an ISO and shall be treated as a NSO on the day three (3) months and one (1) day following such change in status. Except as provided in the Notice and in Sections
6 and 7 below, to the extent that the Option was unvested on the date on which the Optionee’s Service terminates (the “Termination Date”), or if the Optionee does not exercise the vested portion of the Option within the
Post-Termination Exercise Period, the Option shall terminate. 
  
 6. Disability of Optionee. In the event the Optionee’s Service terminates as a result of his death or Disability (as defined below), the Optionee may exercise the portion of the Option that was vested on the Termination Date in
accordance with the terms of Section 5(a) of the Notice; provided, however, that if such Disability is not a “disability” as such term is defined in Section 22(e)(3) of the Code and the Option is an ISO, such ISO shall cease to be treated
as an ISO and shall be treated as a NSO on the day three (3) months and one (1) day following the Termination Date. To the extent that the Option was unvested on the Termination Date, or if the Optionee does not exercise the vested portion of the
Option within the time specified herein, the Option shall terminate. For purposes of this Option Agreement, “Disability” means as defined under the long-term disability policy of the Company or the Parent, Subsidiary or Affiliate of the
Company to which the Optionee provides services regardless of whether the Optionee is covered by such policy. If the Company or the Parent, Subsidiary or Affiliate of the Company to which the Optionee provides service does not have a long-term
disability plan in place, “Disability” means that a Optionee is unable to carry out the responsibilities and functions of the position held by the Optionee by reason of any medically determinable physical or mental impairment for a period
of not less than ninety (90) consecutive days. The Optionee will not be considered to have incurred a Disability unless he furnishes proof of such impairment sufficient to satisfy the Committee in its discretion. Section 22(e)(3) of the Code
provides that an individual is permanently and totally disabled if he or she is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or
which has lasted or can be expected to last for a continuous period of not less than twelve (12) months. 
  
 7. Death of Optionee. In the event of the termination of the Optionee’s Service as a result of his death, the person who acquired the right to
exercise the Option pursuant to Section 8 may exercise the portion of the Option that was vested at the date of termination in accordance with the terms of Section 5(a) of the Notice (but in no event later than the Expiration Date). In the event of
the Optionee’s death during the Post-Termination Exercise Period or during the exercise period following the Optionee’s termination of Service as a result of his Disability, the person who acquired the right to exercise the Option pursuant
to Section 8 may exercise the portion of the Option that was vested at the date of termination within twelve (12) months from 

  

 3 

 
the date of death (but in no event later than the Expiration Date). To the extent that the Option was unvested on the date of death, or if the vested portion
of the Option is not exercised within the time specified herein, the Option shall terminate. 
  
 8. Transferability of Option. The Option, if an ISO, may not be transferred in any manner other than by will or by the laws of descent and distribution and may be exercised during the lifetime of the Optionee
only by the Optionee. The Option, if a NSO, may not be transferred in any manner other than by will or by the laws of descent and distribution, provided, however, that a NSO may be transferred during the lifetime of the Optionee to the extent and in
the manner authorized by the Committee. Notwithstanding the foregoing, the Optionee may designate one or more beneficiaries of the Optionee’s ISO or NSO in the event of the Optionee’s death on a beneficiary designation form provided by the
Committee. Following the death of the Optionee, the Option, to the extent provided in Section 7, may be exercised (a) by the person or persons designated under the deceased Optionee’s beneficiary designation or (b) in the absence of an
effectively designated beneficiary, by the Optionee’s legal representative or by any person empowered to do so under the deceased Optionee’s will or under the then applicable laws of descent and distribution. The terms of the Option shall
be binding upon the executors, administrators, heirs, successors and transferees of the Optionee. 
  
 9. Term of Option. The Option must be exercised no later than the Expiration Date set forth in the Notice or such earlier date as otherwise
provided herein. After the Expiration Date or such earlier date, the Option shall be of no further force or effect and may not be exercised. 
  
 10. Tax Consequences. Set forth below is a brief summary as of the date of this Option Agreement of some of the federal tax consequences of
exercise of the Option and disposition of the Shares. THIS SUMMARY IS NECESSARILY INCOMPLETE, AND THE TAX LAWS AND REGULATIONS ARE SUBJECT TO CHANGE. THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THE OPTION OR DISPOSING OF THE SHARES.

  
 (a) Exercise of ISO. If the Option
qualifies as an ISO, there will be no regular federal income tax liability upon the exercise of the Option, although the excess, if any, of the Fair Market Value of the Shares on the date of exercise over the Exercise Price will be treated as income
for purposes of the alternative minimum tax for federal tax purposes and may subject the Optionee to the alternative minimum tax in the year of exercise. However, the Internal Revenue Service issued proposed regulations which would subject the
Optionee to withholding at the time the Optionee exercises an ISO for Social Security and Medicare based upon the excess, if any, of the Fair Market Value of the Shares on the date of exercise over the Exercise Price. These proposed regulations are
subject to further modification by the Internal Revenue Service and, if adopted, would be effective only for the exercise of an ISO that occurs two years after the regulations are issued in final form. 
  
 (b) Exercise of ISO Following Disability. If the
Optionee’s Service terminates as a result of Disability that is not permanent and total disability as such term is defined in Section 22(e)(3) of the Code, to the extent permitted on the date of termination, the Optionee must exercise an ISO
within three (3) months of such termination for the ISO to be qualified as an ISO. Section 22(e)(3) of the Code provides that an individual is permanently and 

  

 4 

 
totally disabled if he or she is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment
which can be expected to result in death or which has lasted or can be expected to last for a continuous period of not less than twelve (12) months. 
  
 (c) Exercise of NSO. On exercise of a NSO, the Optionee will be treated as having received compensation income (taxable at ordinary
income tax rates) equal to the excess, if any, of the Fair Market Value of the Shares on the date of exercise over the Exercise Price. If the Optionee is an Employee or a former Employee, the Company will be required to withhold from the
Optionee’s compensation or collect from the Optionee and pay to the applicable taxing authorities an amount in cash equal to a percentage of this compensation income at the time of exercise, and may refuse to honor the exercise and refuse to
deliver Shares if such withholding amounts are not delivered at the time of exercise. 
  
 (d) Disposition of Shares. In the case of a NSO, if Shares are held for more than one year, any gain realized on disposition of the
Shares will be treated as long-term capital gain for federal income tax purposes. In the case of an ISO, if Shares transferred pursuant to the Option are held for more than one year after receipt of the Shares and are disposed more than two years
after the Date of Award, any gain realized on disposition of the Shares also will be treated as capital gain for federal income tax purposes and subject to the same tax rates and holding periods that apply to Shares acquired upon exercise of a NSO.
If Shares purchased under an ISO are disposed of prior to the expiration of such one-year or two-year periods, any gain realized on such disposition will be treated as compensation income (taxable at ordinary income rates) to the extent of the
difference between the Exercise Price and the lesser of (i) the Fair Market Value of the Shares on the date of exercise, or (ii) the sale price of the Shares. 
  

11. Entire Agreement: Governing Law. The Notice, the Plan and this Option Agreement constitute the entire agreement of the parties with respect
to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee’s interest except by
means of a writing signed by the Company and the Optionee. Nothing in the Notice, the Plan and this Option Agreement (except as expressly provided therein) is intended to confer any rights or remedies on any persons other than the parties. The
Notice, the Plan and this Option Agreement are to be construed in accordance with and governed by the internal laws of the State of Oregon without giving effect to any choice of law rule that would cause the application of the laws of any
jurisdiction other than the internal laws of the State of Oregon to the rights and duties of the parties. Should any provision of the Notice, the Plan or this Option Agreement be determined to be illegal or unenforceable, such provision shall be
enforced to the fullest extent allowed by law and the other provisions shall nevertheless remain effective and shall remain enforceable. 
  
 12. Headings. The captions used in the Notice and this Option Agreement are inserted for convenience and shall not be deemed a part of the Option
for construction or interpretation. 
  
 13. Administration and
Interpretation. Any question or dispute regarding the administration or interpretation of the Notice, the Plan or this Option Agreement shall be 

  

 5 

 
submitted by the Optionee or by the Company to the Committee. The resolution of such question or dispute by the Committee shall be final and binding on all
persons. 
  
 14. Venue and Waiver of Jury Trial. The
parties agree that any suit, action, or proceeding arising out of or relating to the Notice, the Plan or this Option Agreement shall be brought in the United States District Court for the District of Oregon (or should such court lack jurisdiction to
hear such action, suit or proceeding, in a Oregon state court in the County of Multnomah) and that the parties shall submit to the jurisdiction of such court. The parties irrevocably waive, to the fullest extent permitted by law, any objection the
party may have to the laying of venue for any such suit, action or proceeding brought in such court. THE PARTIES ALSO EXPRESSLY WAIVE ANY RIGHT THEY HAVE OR MAY HAVE TO A JURY TRIAL OF ANY SUCH SUIT, ACTION OR PROCEEDING. If any one or more
provisions of this Section 14 shall for any reason be held invalid or unenforceable, it is the specific intent of the parties that such provisions shall be modified to the minimum extent necessary to make it or its application valid and enforceable.

  
 15. Notices. Any notice required or permitted hereunder
shall be given in writing and shall be deemed effectively given upon personal delivery, upon deposit for delivery by an internationally recognized express mail courier service or upon deposit in the United States mail by certified mail (if the
parties are within the United States), with postage and fees prepaid, addressed to the other party at its address as shown in these instruments, or to such other address as such party may designate in writing from time to time to the other party.

  
 END OF AGREEMENT 
  

 6 

  
 EXHIBIT A

  
 OXIS INTERNATIONAL, INC. 2003 STOCK INCENTIVE PLAN

  
 EXERCISE NOTICE 
  
 OXIS International, Inc. 
 6040 N. Cutter Circle, Suite 317 
 Portland, OR 97217 
  
 Attention: Secretary 
  
 1. Exercise of Option. Effective as of today,
                        ,          the undersigned (the
“Optionee”) hereby elects to exercise the Optionee’s option to purchase                      Common Share (the
“Shares”) of OXIS International, Inc. (the “Company”) under and pursuant to the Company’s 2003 Stock Incentive Plan, as amended from time to time (the “Plan”) and the [    ] ISO
[    ] NSO Agreement (the “Option Agreement”) and Notice of Stock Option Award (the “Notice”) dated
                        ,         . Unless otherwise defined herein, the
terms defined in the Plan shall have the same defined meanings in this Exercise Notice. 
  
 2. Representations of the Optionee. The Optionee acknowledges that the Optionee has received, read and understood the Notice, the Plan and the Option Agreement and agrees to abide by and be bound by their terms
and conditions. 
  
 3. Rights as Stockholder. Until the
stock certificate evidencing such Shares is issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder
shall exist with respect to the Shares, notwithstanding the exercise of the Option. The Company shall issue (or cause to be issued) such stock certificate promptly after the Option is exercised. No adjustment will be made for a dividend or other
right for which the record date is prior to the date the stock certificate is issued, except as provided in Section 9 of the Plan. 
  
 4. Delivery of Payment. The Optionee herewith delivers to the Company the full Exercise Price for the Shares, which, to the extent selected, shall
be deemed to be satisfied by use of the broker-dealer sale and remittance procedure to pay the Exercise Price provided in Section 3(d) of the Option Agreement, to the extent permissible under applicable law. 
  
 5. Tax Consultation. The Optionee understands that the Optionee may
suffer adverse tax consequences as a result of the Optionee’s purchase or disposition of the Shares. The Optionee represents that the Optionee has consulted with any tax consultants the Optionee deems advisable in connection with the purchase
or disposition of the Shares and that the Optionee is not relying on the Company for any tax advice. 
  
 6. Taxes. The Optionee agrees to satisfy all applicable federal, state and local income and employment tax withholding obligations and herewith
delivers to the Company the full amount of such obligations or has made arrangements acceptable to the Company to satisfy such obligations. In the case of an ISO, the Optionee also agrees, as partial consideration for the designation of the Option
as an ISO, to notify the Company in writing within thirty (30) days of 

  

 1 

 
any disposition of any shares acquired by exercise of the Option if such disposition occurs within two (2) years from the Date of Award or within one (1)
year from the date the Shares were transferred to the Optionee. If the Company is required to satisfy any foreign, federal, state or local income or employment tax withholding obligations as a result of such an early disposition, the Optionee agrees
to satisfy the amount of such withholding in a manner that the Committee prescribes. 
  
 7. Successors and Assigns. The Company may assign any of its rights under this Exercise Notice to single or multiple assignees, and this agreement shall inure to the benefit of the successors and assigns of the
Company. This Exercise Notice shall be binding upon the Optionee and his or her heirs, executors, administrators, successors and assigns. 
  
 8. Headings. The captions used in this Exercise Notice are inserted for convenience and shall not be deemed a part of this agreement for
construction or interpretation. 
  
 9. Administration and
Interpretation. The Optionee hereby agrees that any question or dispute regarding the administration or interpretation of this Exercise Notice shall be submitted by the Optionee or by the Company to the Committee. The resolution of such question
or dispute by the Committee shall be final and binding on all persons. 
  
 10. Governing Law; Severability. This Exercise Notice is to be construed in accordance with and governed by the internal laws of the State of Oregon without giving effect to any choice of law rule that would cause the application of
the laws of any jurisdiction other than the internal laws of the State of Oregon to the rights and duties of the parties. Should any provision of this Exercise Notice be determined by a court of law to be illegal or unenforceable, such provision
shall be enforced to the fullest extent allowed by law and the other provisions shall nevertheless remain effective and shall remain enforceable. 
  
 11. Notices. Any notice required or permitted hereunder shall be given in writing and shall be deemed effectively given upon personal delivery,
upon deposit for delivery by an internationally recognized express mail courier service or upon deposit in the United States mail by certified mail (if the parties are within the United States), with postage and fees prepaid, addressed to the other
party at its address as shown below beneath its signature, or to such other address as such party may designate in writing from time to time to the other party. 
  

12. Further Instruments. The parties agree to execute such further instruments and to take such further action as may be reasonably necessary to
carry out the purposes and intent of this agreement. 
  
 13.
Entire Agreement. The Notice, the Plan and the Option Agreement are incorporated herein by reference and together with this Exercise Notice constitute the entire agreement of the parties with respect to the subject matter hereof and supersede
in their entirety all prior undertakings and agreements of the Company and the Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee’s interest except by means of a writing signed by the Company
and the Optionee. Nothing in the Notice, the Plan, the Option Agreement and this Exercise Notice (except as expressly provided therein) is intended to confer any rights or remedies on any persons other than the parties. 
  

 2 

									
	 Submitted by:
	 	 	 	 Accepted by:

			
	 OPTIONEE:
	 	 	 	 OXIS INTERNATIONAL, INC.

					
	 	 	 	 	 	 	 By:
	 	 
					
	 	 	 	 	 	 	 Title:
	 	 
	(Signature)	 	 	 	 	 	 
			
	 Address:
	 	 	 	 Address:

			
	 	 	 	 	 6040 N. Cutter Circle, Suite 317

			
	 	 	 	 	 Portland, OR 97217

  

 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]